0001213900-17-009781.txt : 20170918 0001213900-17-009781.hdr.sgml : 20170918 20170918172032 ACCESSION NUMBER: 0001213900-17-009781 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 63 CONFORMED PERIOD OF REPORT: 20160531 FILED AS OF DATE: 20170918 DATE AS OF CHANGE: 20170918 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURA SYSTEMS INC CENTRAL INDEX KEY: 0000826253 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 954106894 STATE OF INCORPORATION: DE FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-17249 FILM NUMBER: 171090507 BUSINESS ADDRESS: STREET 1: 2335 ALASKA AVE CITY: EL SEGUNDO STATE: CA ZIP: 90245 BUSINESS PHONE: 3106435300 MAIL ADDRESS: STREET 1: 2335 ALASKA AVE CITY: EL SEGUNDO STATE: CA ZIP: 90245 10-Q 1 f10q0516_aurasystemsinc.htm QUARTERLY REPORT

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 31, 2016

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from______________ to ______________

AURA SYSTEMS, INC.

(Exact name of Registrant as specified in its charter)

Delaware		95-4106894
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

10541 Ashdale St.

Stanton, CA 90680

(Address of principal executive offices and zip code)

Registrant's telephone number, including area code: (310) 643-5300

Former name, former address and former fiscal year, if changed since last report:

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: YES ☐ NO ☒

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES ☐ NO ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐ (Do not check if a smaller reporting company)	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of Common Stock, as of the latest practicable date.

Class		Outstanding August 31, 2017
Common Stock, par value $0.0001 per share		126,608,391 shares

AURA SYSTEMS, INC.

INDEX

Index			Page No.

PART I.	FINANCIAL INFORMATION		1

	ITEM 1.	Financial Statements (Unaudited)	1

		Balance Sheets as of May 31, 2016 and February 29, 2016	1

		Statements of Operations for the Three months Ended May 31, 2016 and 2015	2

		Statements of Cash Flows for the Three months Ended May 31, 2016 and 2015	3

		Notes to Financial Statements	4

	ITEM 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	13

	ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	18

	ITEM 4.	Controls and Procedures	18

PART II.	OTHER INFORMATION		19

	ITEM 1.	Legal Proceedings.	19

	ITEM 1A.	Risk Factors.	19

	ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	19

	ITEM 3.	Defaults Upon Senior Securities	20

	ITEM 4.	Mine Safety Disclosures	20

	ITEM 5.	Other Information	20

	ITEM 6.	Exhibits	20

	SIGNATURES AND CERTIFICATIONS		21

ITEM 1. FINANCIAL STATEMENTS

AURA SYSTEMS, INC.
BALANCE SHEETS

(Unaudited)

	As of May 31,			As of February 29,
	2016			2016
ASSETS
Current assets:
Cash and cash equivalents	$	357,311		$	22,175
Accounts receivable,		-			2,115
Other current assets		9,677			16,282
Total current assets		366,988			40,572

Deposits		-			90,213

Total assets	$	366,988		$	130,785

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$	2,293,268		$	1,823,776
Accrued expenses		5,587,418			5,389,883
Customer advances		641,751			641,751
Notes payable		4,182,468			3,927,468
Convertible note payable and accrued interest-related party, net of discount		-			-
Convertible notes payable, net of discount		2,720,700			2,720,700
Notes payable and accrued interest- related party		27,356,841			26,869,911

Total current liabilities		42,782,446			41,373,489

Convertible note payable, net of discount		1,389,337			1,366,922
Convertible note payable and accrued interest-related party, net of discount		2,676,913			2,560,425

Total liabilities		46,848,696			45,300,836

Commitments and contingencies

Stockholders' deficit:
Common stock, $0.0001 par value; 150,000,000 shares authorized at May 31 and February 28, 2015; 113,951,432 and 113,041,432 issued and outstanding at May 31 and February 29, 2016, respectively		11,399			11,304
Additional paid-in capital		410,499,597			410,404,692
Accumulated deficit		(456,992,704	)		(455,586,047	)

Total stockholders' deficit		(46,481,708	)		(45,170,051	)

Total liabilities and stockholders' deficit	$	366,988		$	130,785

The accompanying notes are an integral part of these financial statements.

AURA SYSTEMS, INC.
STATEMENTS OF OPERATIONS
FOR THREE MONTHS ENDED MAY 31, 2016 AND 2015
(Unaudited)

	May 31,
	2016			2015
Net Revenues	$	0		$	106,327
Cost of goods sold		0			73,562
Gross Profit		0			32,765

Operating expenses:
Engineering, research and development expenses		33,788			137,487
Selling, general and administrative expenses		616,977			1,455,689
Total operating expenses		650,765			1,593,176

Loss from operations		(650,765	)		(1,560,411	)

Other (income) and expense:
Interest expense, net		827,947			740,700
Gain on debt settlement		(70,288	)		-
Other income, net		(1,767	)		(59,500	)
Total other (income) expense		755,892			681,200

Net Loss	$	(1,406,657	)	$	(2,241,611	)

Total basic and diluted loss per share	$	(0.01	)	$	(0.02	)
Weighted average shares used to compute basic and diluted loss per share		113,848,171			113,041,432

*Basic and diluted weighted average number of shares are equivalent since the effect of potential dilutive securities is anti-dilutive.

See accompanying notes to these unaudited financial statements.

AURA SYSTEMS, INC.
STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MAY 31, 2016 AND 2015
(Unaudited)

	Three Months Ended May 31,
	2016			2015
Cash flow from operating activities:
Net Loss	$	(1,406,657	)	$	(2,241,611	)
Adjustments to reconcile Net loss to net cash used in operating activities
Depreciation Expense		-			713
Amortization of debt discount		64,110			64,110
Gain on debt settlement		(70,288	)		-
(Increase) decrease in:
Accounts receivable		2,115			54,352
Other current assets and deposit		96,819			39,623
Increase (decrease) in:
Accounts payable, customer deposit and accrued expenses		1,215,829			1,767,075
Net cash used in operations		(98,072	)		(315,740	)

Financing activities:
Proceeds from convertible notes payable		-			-
Proceeds from notes payable-net		405,000			24,000
Proceeds from notes payable-related party, net		28,208			310,000

Net cash provided by financing activities:		433,208			334,000

Net increase (decrease) in cash & cash equivalents		335,136			18,260

Cash and cash equivalents at beginning of period		22,175			34,855

Cash and cash equivalents at end of period	$	357,311		$	53,115
Supplemental disclosures of cash flow information
Cash paid during the period for:
Interest	$	-		$	-
Income taxes		-			-

Unaudited supplemental disclosure of non-cash investing and financing activities:

None

See accompanying notes to these unaudited financial statements.

AURA SYSTEMS, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)

NOTE 1 – ACCOUNTING POLICIES

Accounting principles

In the opinion of management, the accompanying balance sheets and related interim statements of income and comprehensive income, and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s annual report on Form 10-K for the year ended February 29, 2016 filed on September 18, 2017 with the U.S. Securities and Exchange Commission.

Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Recently Issued Accounting Pronouncements

In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03, Interest–Imputation of Interest (Subtopic 835-30) (“ASU 2015-03”), which changes the presentation of debt issuance costs in financial statements. ASU 2015-03 requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. It is effective for annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The new guidance will be applied retrospectively to each prior period presented. The Company is currently in the process of evaluating the impact of adoption of ASU 2015-03 on its balance sheets.

In January 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) 2016-01, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affect the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017, and upon adoption, an entity should apply the amendments by means of a cumulative-effect adjustment to the balance sheet at the beginning of the first reporting period in which the guidance is effective. Early adoption is not permitted except for the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income. The Company is currently evaluating the impact of adopting this guidance.

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Topic 842 affects any entity that enters into a lease, with some specified scope exemptions. The guidance in this Update supersedes Topic 840, Leases. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For public companies, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We are currently evaluating the impact of adopting ASU No. 2016-02 on our financial statements.

In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) that clarifies how to apply revenue recognition guidance related to whether an entity is a principal or an agent. ASU 2016-08 clarifies that the analysis must focus on whether the entity has control of the goods or services before they are transferred to the customer and provides additional guidance about how to apply the control principle when services are provided and when goods or services are combined with other goods or services. The effective date for ASU 2016-08 is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years. The Company has not yet determined the impact of ASU 2016-08 on its financial statements.

In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation, or ASU No. 2016-09. The areas for simplification in this Update involve several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public entities, the amendments in this Update are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted in any interim or annual period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of the amendments in the same period. Amendments related to the timing of when excess tax benefits are recognized, minimum statutory withholding requirements, forfeitures, and intrinsic value should be applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of the beginning of the period in which the guidance is adopted. Amendments related to the presentation of employee taxes paid on the statement of cash flows when an employer withholds shares to meet the minimum statutory withholding requirement should be applied retrospectively. Amendments requiring recognition of excess tax benefits and tax deficiencies in the income statement and the practical expedient for estimating expected term should be applied prospectively. An entity may elect to apply the amendments related to the presentation of excess tax benefits on the statement of cash flows using either a prospective transition method or a retrospective transition method. We are currently evaluating the impact of adopting ASU No. 2016-09 on our financial statements.

In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which provides further guidance on identifying performance obligations and improves the operability and understandability of licensing implementation guidance. The effective date for ASU 2016-10 is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years. In May 2016, the FASB issued ASU 2016-12 “Revenue from Contracts with Customers (Topic 606) - Narrow-Scope Improvements and Practical Expedients,” which amends the guidance on transition, collectability, non-cash consideration, and the presentation of sales and other similar taxes. ASU 2016-12 clarifies that, for a contract to be considered completed at transition, all (or substantially all) of the revenue must have been recognized under legacy GAAP. In addition, ASU 2016-12 clarifies how an entity should evaluate the collectability threshold and when an entity can recognize nonrefundable consideration received as revenue if an arrangement does not meet the standard’s contract criteria. The standard allows for both retrospective and modified retrospective methods of adoption. The Company has not yet determined the impact of ASU 2016-10 on its financial statements.

In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Statements," which requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2019 (fiscal year 2021 for the Company). The Company has not yet determined the potential effects of the adoption of ASU 2016-13 on its Financial Statements.

In August 2016, the FASB issued ASU 2016-15, "Classification of Certain Cash Receipts and Cash Payments," which aims to eliminate diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. ASU 2016-15 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2017 (fiscal year 2019 for the Company). The Company has not yet determined the potential effects of the adoption of ASU 2016-15 on its Financial Statements.

Reclassifications

Certain reclassifications have been made to the comparative financial statements to conform to the current period presentation.

NOTE 2 – GOING CONCERN

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. During the Three months ended May 31, 2016 and May 31, 2015, the Company incurred losses of $1,406,657 and $2,241,611, respectively and had negative cash flows from operating activities of $98,072 and $315,740, respectively.

If the Company is unable to generate profits and is unable to continue to obtain financing for its working capital requirements, it may have to curtail its business sharply or cease business altogether.

Substantial additional capital resources will be required to fund continuing expenditures related to our research, development, manufacturing and business development activities. The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to retain its current financing, to obtain additional financing, and ultimately to attain profitability.

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that could result from the outcome of this uncertainty.

During the next twelve months we intend to restart operations of our AuraGen/VIPER business both domestically and internationally. At the next shareholders meeting the shareholders will vote for an entire new slate of five board candidates. The new board when elected will hire a new management team. In addition we plan to acquire a new facility of approximately 45,000 square feet for operations, as well as, rebuild the engineering QA and sales teams to support the operation. We anticipate being able to fund these additions in the upcoming fiscal year.

NOTE 3 – INVENTORIES

Inventories, stated at the lower of cost (first in first out), or market consisted of the following:

	May 31, 2016			February 29, 2016
Raw materials	$	1,872,720		$	1,858,347
Finished goods		1,568,188			1,558,554
		3,440,908			3,416,901
Inventory reserve		(3,440,908	)		(3,416,901	)
	$	0		$	0

The Company has not operated and therefore has not produced product since late 2015. As a result, while the Company believes that a significant portion of the inventory has value, we are unable to substantiate its demand and market value and as a result have elected to reserve it in its entirety as of May 31, 2016 and February 29, 2016.

NOTE 4 – OTHER CURRENT ASSETS

Other assets of $9,677 and $16,283 are comprised of vendor advances of $2,895 and $16,283 as of May 31, 2016 and February 29, 2016.

NOTE 5 – PROPERTY, PLANT, AND EQUIPMENT

Property, plant, and equipment consisted of the following:

	May 31, 2016			February 29, 2016
Machinery and equipment	$	964,111		$	964,111
Furniture and fixtures		163,302			163,302
		1,127,413			1,127,413
Less accumulated depreciation		(1,127,413	)		(1,127,413	)
Property, plant and equipment, net	$	0		$	0

Depreciation expense was $0 and $713 for the Three months ended May 31, 2016 and May 21, 2015, respectively.

NOTE 6 – NOTES PAYABLE

Notes payable consisted of the following:

	May 31, 2016		February 29, 2016

Demand notes payable, at 10% and 16%	$	4,182,468	$	3,927,468
Convertible Promissory Note dated August 10, 2012, due August 10, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 10^th of each month with the principal payment due on the maturity date. To-date, the Company has not made any interest payments as set forth in this note.		926,024		910,488
Convertible Promissory Note dated October 2, 2012, due October 2, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2^nd of each month with the principal payment due on the maturity date. To-date, the Company has not made any interest payments as set forth in this note.		463,313		456,434
Senior secured convertible notes dated May 7, 2013, due May 7, 2014, convertible into shares of our common stock at a price of $0.75 per share. The note was not repaid.		2,395,700		2,395,700
Senior secured convertible notes dated June 20, 2013, due June 20, 2014, convertible into shares of our common stock at a price of $0.50 per share. The note was not repaid.		325,000		325,000
Convertible notes dated April thru May, 2016. The notes carry an interest rate of 5% and might be converted into shares of Company’s common stock if the shareholders approve a 7:1 reverse stock split.		400,000		-

		8,292,505		8,015,090

Less: Current portion	$	6,903,168	$	6,648,168

Long-term portion	$	1,389,337	$	1,366,922

CONVERTIBLE DEBT

On May 7, 2013, the Company transferred 4 notes payable with a total principal value of $1,000,000 together with accrued interest, and consulting fees to a senior secured convertible note with a principal value of $1,087,000 (“New Kenmont Note”) and warrants to Kenmont Capital Partners (“Kenmont”). The New Kenmont Note has a 1-year maturity date and is convertible into shares of common stock at the conversion price of $0.75 per share. The warrants entitle the holder to acquire 1,449,333 shares and have an initial exercise price of $0.75 per share, and have a 7-year term. The Company recorded $342,020 as a discount, which is being amortized over the life of the note. As of the date of filing, the Company has not made any interest payments under the Kenmont Note.

On May 7, 2013, the Company transferred 2 note payables with a total principal value of $550,000 together with accrued interest to a senior secured convertible note with a principal value of $558,700 (“New LPD Note”) and warrants to LPD Investments, Ltd. (“LPD”). The New LPD Note has a 1-year maturity date and is convertible into shares of common stock at the conversion price of $0.75 per share. The warrants entitle the holder to acquire 744,933 shares and have an initial exercise price of $0.75 per share, and have a 7-year term. The Company recorded $175,793 as a discount, which is being amortized over the life of the note. As of the date of filing, the Company has not made any interest payments under the New LPD Note.

On May 7, 2013, the Company entered into an agreement with an individual for the sale of a $750,000 of secured convertible note payable and warrants. The note has a 1-year maturity date and is convertible into shares of common stock at the conversion price of $0.75 per share. The warrants entitle the holder to acquire 1,000,000 shares and have an initial exercise price of $0.75 per share, and have a 7-year term. The Company recorded $235,985 as a discount, which is being amortized over the life of the note. As of the date of filing, the note has not been repaid and is currently accruing interest at the rate of 16%.

On June 20, 2013, the Company entered into an agreement with four individuals for the sale of $325,000 of secured convertible notes payable and warrants. These notes have a 1-year maturity date and are convertible into shares of common stock at the conversion price of $0.50 per share. The warrants entitle the holders to acquire 433,334 shares and have an initial exercise price of $0.75 per share, and have a 7-year term. The Company recorded $63,622 as a discount, which is being amortized over the life of these notes. As of the date of filing, these notes have not been repaid and are currently accruing interest at the rate of 16%.

On August 19, 2013, the Company entered into an agreement with a member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Director Note”) and warrants. The Director Note carries a base interest rate of 9.5%, has a 4-year maturity date and is convertible into shares of common stock at the conversion price of $0.50 per share. The warrant entitles the holder to acquire 5,000,000 shares at an initial exercise price of $0.75 per share for a 7-year exercise period. The Company recorded $667,118 as a discount, which is being amortized over the life of the Director Note. On June 20, 2013, $500,000 of this Director Note was converted to a demand note payable.

Future maturities of notes payable at May 31, 2016 are as follows:

Year Ending February 28,
2017	$	1,389,337
Total	$	1,389,337

7% Convertible Promissory Notes:

On August 10, 2012 the Company entered into an agreement with an individual for the sale of an unsecured convertible promissory note in the amount of $1,000,000. The note’s balance together with all accrued interest thereon shall be due and payable on August 10, 2017 and the annual interest rate is 7% per annum and is due to be repaid 5 years from the closing date. The note holder will receive interest on the unpaid principal amount payable monthly in arrears on the tenth day of each calendar month commencing September 10, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year. The note holder has the right from and after the date of issuance, and until any time until the note is fully paid, to convert any outstanding and unpaid principal portion of the note into shares of the Company’s common stock. The company recorded $310,723 as a debt discount, which is being amortized over the life of the note. As of the date of filing, no payments of interest or principal have been made by the Company on this note.

On October 2, 2012 the Company entered into an agreement with an individual for the sale of an unsecured convertible promissory note in the amount of $500,000. The note’s balance together with all accrued interest thereon shall be due and payable on October 2, 2017 and the annual interest rate is 7% per annum and is due to be repaid 5 years from the closing date. The note holder will receive interest on the unpaid principal amount payable monthly in arrears on the second day of each calendar month commencing November 2, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year. The note holder has the right from and after the date of issuance, and until any time until the note is fully paid, to convert any outstanding and unpaid principal portion of the note into shares of the Company’s common stock. The company recorded $137,583 as a debt discount, which is being amortized over the life of the note. As of the date of filing, no payments of interest or principal have been made by the Company on this note.

NOTE 7 – ACCRUED EXPENSES

Accrued expenses consisted of the following:

	May 31, 2016		February 29, 2016

Accrued payroll and related expenses	$	3,146,841	$	3,148,841
Accrued rent		214,774		218,025
Accrued interest		2,135,804		1,933,017
Other		90,000		90,000
Total	$	5,587,419	$	5,389,883

Accrued payroll and related expenses consists of salaries and vacation time accrued but not paid to employees due to our lack of financial resources.

NOTE 8 – SHAREHOLDERS’ EQUITY

Common Stock

During the three months ended May 31, 2016, we issued 950,000 shares of common stock were issued in settlement for a note payable balance $150,000 plus accrued interest of $15,288.

During the three months ended May 31, 2015, we did not issue any shares of common stock.

Employee Stock Options

During the Three months ended May 31, 2016, there were no stock options granted to employees.

In September, 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan. Activity in this plan is as follows:

	2006 Plan
	Weighted- Average Exercise Price		Aggregate Intrinsic Value		Number of Options
Outstanding, February 29, 2016		$0.75-$1.00	$	0.00		7,224,000
Cancelled		-		-		-
Granted		-		-		-
Outstanding, May 31, 2016		$0.75-$1.00	$	0.00		7,224,000

The exercise prices for the options outstanding at May 31, 2016, and information relating to these options is as follows:

Options Outstanding

Exercisable Options

Range of Exercise
Price

Number

Weighted
Average
Remaining
Life

Weighted
Average
Exercise
Price

Weighted
Average
Remaining
Life

Number

Weighted
Average
Exercise
Price

$0.75-$1.00

7,224,000

3.75 years

0.79

3.75 years

7,224,000

0.79

Warrants

Activity in issued and outstanding warrants is as follows:

	Number of Shares			Exercise Prices
Outstanding, February 29, 2016		36,726,208			$0.10-$1.50
Granted		-			-
Exercised		-			-
Cancelled		(1,657,188	)		$1.00-$1.50
Outstanding, May 31, 2016		35,069,020			$0.10-$1.50

There were no warrants issued in the three months ended May 31,2016.

The exercise prices for the warrants outstanding at May 31, 2016, and information relating to these warrants is as follows:

Range of Exercise Prices	Stock Warrants Outstanding		Stock Warrants Exercisable		Weighted- Average Remaining Contractual Life	Weighted- Average Exercise Price of Warrants Outstanding		Weighted- Average Exercise Price of Warrants Exercisable		Intrinsic Value
$0.10-$0.75		19,481,012		19,481,012	58 months	$	0.56	$	0.56	$	0.00
$0.75		1,082,734		1,082,734	57 months	$	0.75	$	0.75	$	0.00
$0.75		1,000,000		1,000,000	47 months	$	0.75	$	0.75	$	0.00
$0.75-$1.00		5,990,275		5,990,275	42 months	$	0.77	$	0.77	$	0.00
$1.00-$1.25		795,000		795,000	4 months	$	1.05	$	1.05	$	0.00
$1.00		6,719,999		6,719,999	3 months	$	1.00	$	1.00	$	0.00

		35,069,020		35,069,020

NOTE 9 – INCOME TAXES

Our effective tax rates were approximately 0.0% for the three months ended May 31, 2016 and 2015. Our effective tax rate was lower than the U.S. federal statutory rate primarily due to the fact that we record a full valuation allowance against our deferred tax assets, which is primarily comprised of net operating losses.

NOTE 10 – SEGMENT INFORMATION

We are a United States based company providing advanced technology products to various industries. The principal markets for our products are North America, Europe, and Asia. All of our operating long-lived assets are located in the United States. We operate in one segment.

Total net revenues from customer geographical segments are as follows for the three months ended May 31, 2016 and 2015:

	2016		2015

United States	$	0	$	30,124
Canada		-		-
Europe		-		210
Asia		-		20,014
Other		-		55,979
Total	$	0	$	106,327

NOTE 11 – SIGNIFICANT CUSTOMERS

Concentration Risk

In the three months ended May 31, 2016, we did not have any sales to customers. In the Three months ended May 31, 2015, we sold AuraGen related products to three significant customers whose sales comprised 45%, 32% and 17% of sales, respectively. Net accounts receivable from these customers at May 31, 2015 were $0, $0 and $0 respectively. These customers are not related to or affiliated with us.

NOTE 12 – RELATED PARTIES TRANSACTIONS

At May 31, 2016, the balance reflected in Notes Payable and accrued interest-related party, current, includes $14,903,252 of unsecured notes payable plus accrued interest of $8,054,541 to Mr. Brelow, a member of our Board of Directors, payable on demand, bearing interest at a rate of 10% per annum. The balance of $14,880,372 plus accrued interest of $7,680,164 as of February 29, 2016. During the three months ended May 31, 2015 and May 31, 2015, interest amounting to $374,378 and $359,762 respectively, was incurred on these notes. The balance also includes $82,000 of unsecured notes payable plus accrued interest of $25,748 and $23,704 to our CEO pursuant to a demand note entered into on April 5, 2013 and an unsecured note payable to Mr. Kopple, another member of our Board of Directors in the total amount of $3,424,064 and $3,418,738 plus accrued interest of $867,234 and $784,934 with interest at a rate of 10% per annum as of May 31, 2016 and February 29, 2016, respectively.

At May 31, 2016, the balance reflected in Convertible note payable and accrued interest-related party, long term, includes $1,880,851 of secured convertible notes payable net of discounts of $119,149 plus accrued interest of $796,063 to Mr. Kopple, a member of our Board of Directors.

NOTE 13 – COMMITMENTS

Our facilities consist of approximately 20,000 rented square feet in Stanton, California. The Stanton facility is currently being used for small quantity assembly and testing using components that are produced by various suppliers as well as for general offices, engineering and warehousing. The rent for the Stanton facility is $10,000 per month. The facility is not sufficient for our near term anticipated needs and the Company is actively looking for a new facility. The Company arrangements for the Stanton facility are on a month per month rent.

NOTE 14 – SUBSEQUENT EVENTS:

On January 24, 2017 the Company entered into a Debt Refinancing Agreement with Mr. Breslow, a Director of the Company. Pursuant to the agreement, both Mr. Breslow and the Company acknowledged that total debt owed to Mr. Breslow was $23,872,614 including $8,890,574 of accrued interest. Mr. Breslow agreed to cancel and forgive all interest due, waive all events of default and sign a new five year convertible note in the amount of $14,930,041 providing for no interest for six months and interest of 5% per annum thereafter payable monthly in arrears. The note also provides various default provisions. The agreement further provides that $11,982,041 of the note will be converted into 7,403,705 shares of common stock concurrent with the stockholders approving a 1 for 7 reverse stock split within one year of entering this agreement and the remaining may be converted at any time thereafter post reverse split. In the absence of the approval within one year, this agreement will become null and void. The Company has elected to continue to accrue interest on this agreement until such time as the 1 for 7 reverse stock split has been approved.

On January 30, 2017, the Company entered into an agreement with five of our secured creditors (the “Secured Creditors”), pursuant to which a Securities Purchase Agreement dated May 6, 2013 (the “2013 Purchase Agreement”) among the Company, the Secured Creditors, and two other parties was amended (the “Amended Agreement”). As part of the 2013 transaction, we entered into a security agreement with the Secured Creditors and two other parties (collectively the “Buyers”) pursuant to which the Buyers were granted a security interest in all of Company’s assets except for its patents and other intellectual properties. The Secured Creditors have the right to amend the 2013 Purchase Agreement on behalf of all Buyers. The Amended Agreement amends the 2013 Purchase Agreement and the original security agreement, replaces the convertible notes with “Amended Notes” and replaces the warrants with “Amended Warrants.” The Amended Notes provide that all accrued and unpaid interest on the original notes through October 31, 2016 be added to the principal amount of the Amended Notes. The Amended Notes bear interest at the rate of 0% until May 1, 2017 and 5% per annum thereafter, subject to reduction to comply with applicable law, and mature in 60 months from the effective date of a 1 for 7 reverse stock split. Upon certain financings, the Company is obligated to make a payment to the holders of the Amended Notes in the amount of 20% of the outstanding Notes. Immediately upon the effectiveness of a 1 for 7 reverse stock split, 80% of the then-unpaid principal of and all of the then accrued but unpaid interest on the Amended Notes is automatically converted. In addition, the Amended Agreement waives any and all events of default under the 2013 Purchase Agreement and related transaction documents existing on or prior to January 30, 2017 and amends the defaults and remedies section of the 2013 Purchase Agreement. Two Buyers, who together represent less than 3% of the Company’s common stock issuable upon conversion of the original notes and exercise of the original warrants, did not sign the amendment and have named the Company and the Company’s Chief Executive Officer among several defendants in a lawsuit demanding repayment of loans totaling $125,000 plus accrued interest and exemplary damages. Management believes that the two plaintiffs have no valid claim against the Company or our Chief Executive Officer. In March 2017, plaintiffs moved for partial summary adjudication against the Company and our Chief Executive Officer; however, the Court denied plaintiffs’ motion. Both the Company and Mr. Gagerman have filed demurrers seeking dismissal of this action, which remain pending at this time.

On January 27, 2017, the Company entered into a joint venture (JV) agreement with a Chinese company to manufacture, market and distribute certain mobile power products based on Aura's patented technology solely for the Peoples Republic of China territories. The JV will be owned 49% by the Company and 51% by the Chinese company who will also contribute $9,750,000 to the JV. The Company is required to contribute $250,000 and a license to specific technology. In addition, the Chinese company will invest $2,000,000 in Aura at $0.20 per share for a total of 10,000,000 shares of common stock and purchase a minimum of $1,250,000 of product supported by letters of credit for distribution until the JV factory is built, equipped, and staffed. Aura has also committed to supply training and technical personnel to the JV for six months at no cost other than reimbursement for travel, room and board. The agreement was subject to the approval of the Chinese Government which was received in April, 2017.

The Company is presently engaged in a dispute with one of its directors, Robert Kopple, relating to approximately $5.4 million and approximately 22 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company. In July 2017, Mr. Kopple filed suit against the Company as well as against current Directors Mr. Gagerman and Mr. Diaz-Verson together with former Directors Mr. Breslow and Mr. Howsmon in connection with these allegations. The Company believes that it has valid defenses in these matters and intends to vigorously defend against these claims.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

This Report contains forward-looking statements within the meaning of the federal securities laws. Statements other than statements of historical fact included in this Report, including the statements under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” regarding future events or prospects are forward-looking statements. The words “approximates,” “believes,” “forecasts,” “expects,” “anticipates,” “estimates,” “intends,” “plans” “would,” “could,” “should,” “seek,” “may,” or other similar expressions in this Report, as well as other statements regarding matters that are not historical fact, constitute forward-looking statements. We caution investors that any forward-looking statements presented in this Report are based on the beliefs of, assumptions made by, and information currently available to, us. Such statements are based on assumptions and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results may differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on forward-looking statements to anticipate future results or trends.

Some of the risks and uncertainties that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include the following:

	●	Our ability to generate positive cash flow from operations;

	●	Our ability to obtain additional financing to fund our operations;

	●	The impact of economic, political and market conditions on us and our customers;

	●	The impact of unfavorable results of legal proceedings;

	●	Our exposure to potential liability arising from possible errors and omissions, breach of fiduciary duty, breach of duty of care, waste of corporate assets and/or similar claims that may be asserted against us;

	●	Our ability to compete effectively against competitors offering different technologies;

	●	Our business development and operating development;

	●	Our expectations of growth in demand for our products; and

●

Other risks described under the heading “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form 10-Q and those risks discussed in our other filings with the Securities and Exchange Commission, including those risks discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended February 29, 2016 (as the same may be updated from time to time in subsequent quarterly reports), which discussion is incorporated herein by this reference.

We do not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent required by law. You should interpret all subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf as being expressly qualified by the cautionary statements in this Report. As a result, you should not place undue reliance on these forward-looking statements.

Overview

Our business is based on the exploitation of our patented mobile power solution known as the AuraGen for commercial and industrial applications and the VIPER for military applications. Our business model consists of three major components: (i) sales and marketing, (ii) engineering, and (iii) customer service and support.

(i) Our sales and marketing approach is composed of direct sales in North America and the use of agents, distributors and joint ventures for sales internationally. In North America, our primary focus is in (a) transport refrigeration, and (b) U.S. Military applications.

(ii) The second component of our business model is focused on the engineering support for the sales activities described above. The engineering support consists of the introduction of new features for our AuraGen/VIPER solution such as higher power, different voltages, three phase options, shore power systems, higher current solutions as well as interface kits for different platforms.

(iii) The third component of our business model is customer service. In fiscal 2018, we expect to rehire several previously trained field engineers to support our product in North America. In addition, we are working closely with our Chinese Joint Venture partner to train their staff to support our products overseas.

During the first half of fiscal 2016, the Company significantly reduced operations due to lack of financial resources. During the second half of fiscal 2016 the Company’s operations were disrupted when the Company was forced to move from its facilities in Redondo Beach, California to a smaller facility in Stanton, California. Operations during the second half of fiscal 2016 were sporadic. During fiscal 2017, the Company suspended its engineering, manufacturing, sales, and marketing activities to focus on renegotiating numerous financial obligations.

The Company has been successful in restructuring its secured debt and has reached an agreement with its secured creditors whereby all defaults and penalties have been waived and 80% of the secured debt will be converted into shares of the Company’s common stock as soon as the Company holds an annual meeting of stockholders to elect a new board of directors. The balance (the remaining 20%), is to be paid to the secured creditors in cash if the Company raises at least $4.0 million in proceeds through new equity offering. Upon conversion, the converting secured creditors will receive approximately 3.9 million new common shares in exchange for approximately $5.73 million of converting debt.

The Company has also been successful in restructuring approximately $27.5 million of unsecured debt. Various unsecured creditors have agreed to waive all defaults and penalties, to forgive an aggregate of approximately $9.3 million in debt, and convert an aggregate of approximately $15.2 million of unsecured debt into approximately 10.2 million common shares. As of the date of this filing, Robert Kopple, the Company’s Vice Chairman of the Board, is the only significant unsecured note holder that has not agreed to restructure his debt. Mr. Kopple claims to be owed approximately $5.4 million on terms significantly preferable to other similarly-situated unsecured creditors. Mr. Kopple has not accepted the Company’s offer to restructure this debt to-date.

Our financial statements included in this report have been prepared on the assumption that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. However, as a result of our losses from operations, there is substantial doubt about our ability to continue as a going concern. Our independent auditors, in their report on the Company’s financial statements for the year ended February 29, 2016 expressed substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amount and classification of liabilities that may result from our possible inability to continue as a going concern.

Our ability to continue as a going concern is dependent upon the successful achievement of profitable operations, and the ability to generate sufficient cash from operations and obtain financing resources to meet our obligations. There is no assurance that such efforts will be successful.

Our current level of sales reflects our efforts to introduce a new product into the marketplace. Until recently, many purchases of the product were for evaluation purposes. Recently we started to receive repeat orders for larger quantities as different organizations are integrating our products into their vehicles. We seek to achieve profitable operations by obtaining market acceptance of the AuraGen^® as a competitive - if not superior - product providing mobile power anywhere anytime. There can be no assurance that this success will be achieved.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of financial statements requires management to make estimates and disclosures on the date of the financial statements. On an on-going basis, we evaluate our estimates, including, but not limited to, those related to revenue recognition. We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments. Actual results could differ from those estimates. We believe that the following critical accounting policies affect our more significant judgments and estimates in the preparation of our consolidated financial statements.

Revenue Recognition

We are required to make judgments based on historical experience and future expectations, as to the reliability of shipments made to our customers. These judgments are required to assess the propriety of the recognition of revenue based on Staff Accounting Bulletin ("SAB") No. 101, "Revenue Recognition," and related guidance. Because sales are currently in limited volume and many sales are for evaluative purposes, we have not booked a general reserve for returns. We will consider an appropriate level of reserve for product returns when our sales increase to commercial levels.

Inventory Valuation and Classification

Inventories consist primarily of components and completed units for our AuraGen^® product. Inventories are valued at the lower of cost (first-in, first-out) or market. Provision is made for estimated amounts of current inventories that will ultimately become obsolete due to changes in the product itself or vehicle engine types that go out of production. Management believes that existing inventories can, and will, be sold in the future without significant costs to upgrade it to current models and that the valuation of the inventories accurately reflects the realizable values of these assets. The AuraGen^® product being sold currently is not technologically different from those in current use. Existing finished goods inventories can be upgraded to the current model with only a small amount of materials and manpower. We make these assessments based on the following factors: i) existing orders, ii) age of the inventory, iii) historical experience and iv) our expectations as to future sales. If expected sales volumes do not materialize, there would be a material impact on our financial statements.

Valuation of Long-Lived Assets

Long-lived assets, consisting primarily of property and equipment, and patents and trademarks, comprise a portion of our total assets. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying values August not be recoverable. Recoverability of assets is measured by a comparison of the carrying value of an asset to the future net cash flows expected to be generated by those assets. Net cash flows are estimated based on expectations as to the realize-ability of the asset. Factors that could trigger a review include significant changes in the manner of an asset’s use or our overall strategy.

Specific asset categories are treated as follows:

Accounts Receivable: We record an allowance for doubtful accounts based on our expectation of collect-ability of current and past due accounts receivable.

Property, Plant and Equipment: We depreciate our property and equipment over various useful lives ranging from five to ten years. Adjustments are made as warranted when market conditions and values indicate that the current value of an asset is less than its net book value.

When we determine that an asset is impaired, we measure any such impairment by discounting an asset’s realizable value to the present using a discount rate appropriate to the perceived risk in realizing such value. When we determine that an impaired asset has no foreseeable realizable value, we write such asset down to zero.

Results of Operations

Three months ended May 31, 2016 compared to three months ended May 31, 2015

Net revenues for the three months ended May 31, 2016 (the “First Quarter FY2017”) decreased $106,327 to $0 from $106,327 in the three months ended May 31, 2015 (the “First Quarter FY2016”). The Company has virtually ceased operations due to a lack of funding.

Cost of goods decreased $73,562 to $0 in the First Quarter FY2017 from $73,562 in the First Quarter FY2016 as a result of the virtual cessation of operations as noted above.

Engineering, research and development expenses decreased $103,699 (75%) to $33,788 in the First Quarter FY2017 from $137,487 in the First Quarter FY2016. The decline is attributable to a lack of funds resulting in the virtual cessation of operations as noted above.

Selling, general and administrative expense decreased $838,712 (58%) to $616,977 in the First Quarter FY2017 from $1,455,689 in the First Quarter FY2016. As noted above, the decrease is primarily attributable to the curtailment of activities due to a lack of financial resources.

Net interest expense in the First Quarter FY2017 increased $87,246 (12%) to $827,947 from $740,701 in the First Quarter FY2016 due to our increased debt levels.

Our net loss for the First Quarter FY2017 decreased $834,954 to $1,406,657 from $2,241,611 in the First Quarter FY2016, as a result of the overall decrease in operations due to the lack of financial resources.

Liquidity and Capital Resources

We had cash of approximately $357,000 and $22,000 as of May 31, 2016, and February 29, 2016, respectively. We had a working capital deficit at May 31, 2016, and February 29, 2016 of $42,415,458 and $41,332,917, respectively. The working capital deficit includes notes payable and accrued interest to related parties of $27,356,841 and $26,869,911 as of May 31 and February 29, 2016, respectively. As of May 31, 2016, we had accounts receivable, net of allowance for doubtful accounts, of $0 compared to $2,115 as of February 29, 2016.

Net cash used in operations for the Three months ended May 31, 2016, was $98,072, a decrease of $217,668 from the comparable period in the prior fiscal year. Net cash provided by financing activities during the Three months ended May 31, 2016, was $433,208, resulting from net proceeds from notes payable.

There were no acquisitions of property and equipment in the Three months FY 2017 or the Three months FY 2016.

Accrued expenses as of May 31, 2016 increased $197,535 to $5,587,418 from $5,389,883 as of February 29, 2016. Approximately $1,335,000 of accrued expenses is salaries accrued but unpaid to certain employees and ex-employees due to a lack of resources, and approximately $518,000 is accrued but unused vacation time earned by employees.

Net proceeds from the issuance of debt totaled $443,208 in the Three months FY 2017, compared with $334,008 in the Three months FY 2016. As of May 31, 2016, the total amount owing a board member is $14,903,252 plus accrued interest of approximately $8,055,000. We also owe another Board member a total of $5,304,457, net of discounts of $119,150 plus accrued interest of approximately $1,663,296. If the Board members were to demand repayment, we do not currently have the resources to make the payments.

The Company had a deficit of $46,481,708 in shareholders’ equity as of May 31, 2016, compared to $45,170,051 as of February 29, 2016.

Since 2002 substantially all of our revenues from operations have been derived from sales of the AuraGen^®. The cash flow generated from our operations to date has not been sufficient to fund our working capital needs, and we cannot predict when operating cash flow will be sufficient to fund working capital needs.

In the past, in order to maintain liquidity we have relied upon external sources of financing, principally equity financing and private indebtedness. We have no bank line of credit and require additional debt or equity financing to fund ongoing operations. The issuance of additional shares of equity in connection with any such financing could dilute the interests of our existing stockholders, and such dilution could be substantial. If we cannot raise needed funds, we would also be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.

Capital Transactions

During the quarter ended May 31, 2016, we issued 950,000 shares of common stock to settle a note payable balance of $150,000 plus accrued interest of $15,588.

During the quarter ended May 31, 2015, we did not issue any shares of common stock.

Inventories

Inventories consist primarily of components and completed units of the Company’s AuraGen^® product.

Early in our AuraGen^® program, we determined it was most cost-effective to outsource production of components and subassemblies to volume-oriented manufacturers, rather than produce these parts in house. As a result of this decision, and based on then anticipated sales, we purchased, prior to fiscal 2001, a substantial inventory of components at volume prices. Since sales did not meet such expectations, we have been selling product from this inventory for several years.

Most of our inventory consists of a variety of (i) metallic, mechanical components, and (ii) electrical components including metallic chassis to hold the assembled electrical systems. The vast majority of mechanical components are not aged and most of the electrical components are also not aged. The components that are aged are related to the prime mover/Generator interface that may not be in demand any longer.

In the past we have offered and ship three different basic models of systems; (i) a 5 kW based systems, (ii) an 8.5 kW based system and (iii) a 16 kW based systems (two 8.5 kW systems configured in tandem back-to-back). Each of these systems can be configured with different options such as 110 VAC only, 220 VAC only, 24 VDC only, 12 VDC only and AC/DC combinations of the same or different voltages. In addition, the system can be configured with single phase, split phase or three-phase output.

A number of the mechanical components are common to all three of the above configurations, while others are very specific. For example, the stators and rotors for the 5 kW systems are different from the 8.5 kW systems, but the housings are the same. Similarly, the electrical components consist of some parts that are geared for a specific configuration while others are generic and can be used for all of the configurations. The electrical chassis are also interchangeable between the 5 kW and 8.5 kW configurations. Due to the nature and mix of the product being sold, frequently, the 5 kW electrical systems are upgraded to 8.5 kW systems by replacing some components.

From the above description one can understand that the inventory consists of numerous components and subassemblies but not finished systems; therefore, each system that is sold and shipped to a customer is built from some components that are in inventory and others that need to be purchased to be able to configure the required system.

8.5 kW systems represent the majority of product previously shipped. These systems are built by using existing inventory subassemblies and parts, including some that can be used for both 5 kW and 8.5 kW systems, and additional parts that are purchased to provide the required configuration. Typically, such systems are built using approximately 20 to 25 percent of existing inventory and approximately 75% of additional parts that are purchased.

However, most of the systems sold to the Korean military consist of 5 kW systems. They have been purchasing approximately 100 systems per year and have indicated to us that they will continue to do so for the next five years. To date we have shipped over 500 such systems (in this case 100% of the rotors and stators are used from existing inventory and over 50% of the electrical parts are also from inventory).

In addition to the above, we have encountered demand for different and unique configurations that require the purchase of additional parts.

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, we are not required to provide disclosure under this Item 3.

ITEM 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the specified time periods. For the last 3 fiscal years, these control and procedures broke down due to insufficient capital to maintain such controls and procedures. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to its management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. As of the end of the period covered by this report, the Company’s management evaluated, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, the effectiveness of the Company’s disclosure controls and procedures. Based on the evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that these controls and procedures were ineffective for the last 3 fiscal years in ensuring that information requiring disclosure is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting during our fiscal quarter ended May 31, 2016, which have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. Legal Proceedings

We are subject to the legal proceedings and claims discussed below as well as certain other legal proceedings and claims that have not been fully resolved and that have arisen in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and evaluates potential losses on such litigation if the amount of the loss is estimable and the loss is probable. However, the outcome of legal proceedings and claims brought against the Company is subject to significant uncertainty. Although management considers the likelihood of such an outcome to be remote, if one or more of these legal matters were resolved against the Company for amounts in excess of management’s expectations, the Company’s consolidated financial statements for that reporting period could be materially adversely affected. The Company settled certain matters subsequent to year end that did not individually or in the aggregate have a material impact on the Company’s financial condition or operating results.

In 2016, the Company was sued by a former employee for a work-related injury. The plaintiff is seeking $45,000. The Company has made the plaintiff a settlement offer which, as of the date of this filing, has not been accepted.

In November 2016, the Company was sued by a former customer for approximately $111,712 relating to an alleged failure by the Company to partially deliver against an advanced payment. In connection with its claims, the plaintiff has asserted that by virtue of the Company’s failure to fully deliver upon the contracted order, the plaintiff has obtained a perpetual worldwide license to utilize the Company’s actuator technology. The Company disputes the plaintiff’s claims and believes that it holds various claims against the plaintiff. In April 2017, the plaintiff’s action was involuntarily dismissed by the court although plaintiff sought to have the dismissal set aside on the grounds of attorney error. In June 2017, the court granted plaintiff’s motion and the Company intends to oppose this action and file a counterclaim.

Subsequent to year end, the Company’s former COO has been awarded approximately $238,000 in accrued salary and related charges by the California labor board. The Company believes that this award does not reflect the amount owed which is significantly lower and is exploring all its options and available remedies and is working toward an offer to settle this matter.

The Company and the Company’s Chief Executive Officer, Melvin Gagerman, are among several defendants named in a lawsuit filed by two secured creditors demanding repayment of loans totaling $125,000 plus accrued interest and exemplary damages. In January 2017, the Company entered into an agreement with all secured creditors other than the two plaintiffs. However, because secured creditors holding in excess of 97% of the issuable stock upon conversion have executed the agreement, the agreement is binding on all of the secured creditors, including the two plaintiffs. That agreement, among other provisions, waives all past events of default. It is the Company’s position that the two plaintiffs are not entitled to any payment or other relief at this time and therefore that they have no valid claim against the Company or Mr. Gagerman. In March 2017, plaintiffs moved for partial summary adjudication against the Company and Mr. Gagerman; however, the Court denied plaintiff’s motion. Thereafter, the Court sustained demurrers by Mr. Gagerman and the Company but granted plaintiffs leave to amend. In response to the plaintiffs’ second amended complaint, both the Company and Mr. Gagerman intend to further demurrer seeking dismissal of this action.

In June 2015, the landlord of the Company’s primary facility in Redondo Beach, California initiated litigation against us seeking to terminate the Company’s lease and require the Company to vacate the premises prior to the scheduled lease end. As a result of that litigation, the Company was forced to vacate its primary facility and relocate to its present facility in Stanton, California. To date, no action seeking damages or any other amount has been filed against the Company by the landlord, nor does the Company believe it has any further liability to the landlord.

ITEM 1A. Risk Factors.

In addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Item 1A, “Risk Factors,” of the Company’s annual report on Form 10-K for the year ended February 29, 2016.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the quarter ended May 31, 2016, we did not issue any shares of common stock.

All of the sales of unregistered securities are believed to be exempt from registration pursuant to Section 4(2) of the Securities Act of 1933 as these offerings were a private placement to a limited number of qualified investors without public solicitation or advertising.

ITEM 3. Defaults Upon Senior Securities.

We have commitments to pay investors and lenders $40,553,920 comprising principal and accrued interest on various convertible notes, non-convertible notes and loans payable through May 31, 2016. Due to our lack of financial resources, the Company was unable to make various required principal and interest payments under a number of notes payable, and was in potential default on $13,535,679 of such debt as of May 31, 2016.

In 2017, the Company has been successful in restructuring a total of approximately $33.7 million of debt (the “Restructured Debt”) through agreements reached with all of the Company’s secured creditors and the majority of the Company’s unsecured creditors. Pursuant to these restructuring agreements, any and all defaults and penalties with respect to the Restructured Debt have been waived, approximately $9.3 million in accrued interest has been forgiven, and approximately $20.9 million will be converted into approximately 14.1 million shares of the Company’s common stock upon stockholder approval of a 1-for-7 reverse stock split and the election a new board of directors. Of the $13,535,679 of notes payable in potential default as of May, 31, 2016, $6,245,841 was subsequently restructured in 2017 and any potential defaults with respect to this amount have been resolved.

As of the date of this filing, Robert Kopple, the Company’s Vice Chairman of the Board, is the only significant unsecured note holder that has not agreed to restructure his debt. Mr. Kopple claims to be owed approximately $5.4 million plus interest and approximately 22 million warrants on terms significantly preferable to other similarly-situated unsecured creditors. To-date, Mr. Kopple has not accepted the Company’s multiple offers to restructure his debt. The Company is presently engaged in a dispute with Mr. Kopple relating to the debt and securities which Mr. Kopple claims to be owed to him and his affiliates by the Company. See, “Note 6 – Notes Payable”, “Note 12 – Related Parties Transactions”, “Note 14 –Subsequent Events” to the Company’s condensed financial statements and “Liquidity and Capital Resources” in “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” elsewhere in this quarterly report on Form 10-Q for additional information regarding amounts that may be owed under the Company’s notes payable and the recent restructuring of certain Company debt.

ITEM 4. Mine Safety Disclosures

Not applicable.

ITEM 5. Other Information.

None.

ITEM 6. Exhibits

31.1	Certifications pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.

31.2	Certifications pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.

32.1	Certification of CEO and CFO Pursuant to 18 U.S.C. § 1350, as Adopted Pursuant to § 906 of the Sarbanes-Oxley Act of 2002.

101.INS	XBRL Instance Document

101.SCH	XBRL Schema Document

101.CAL	XBRL Calculation Linkbase Document

101.DEF	XBRL Definition Linkbase

101.LAB	XBRL Label Linkbase Document

101.PRE	XBRL Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

AURA SYSTEMS, INC.
(Registrant)

Date: September 18, 2017

By:	/s/ Melvin Gagerman
Melvin Gagerman
Acting Chief Financial Officer
(Principal Financial and Accounting Officer
and Duly Authorized Officer)

EX-31.1 2 f10q0516ex31-1_aurasystem.htm CERTIFICATION

Exhibit 31.1

CERTIFICATION

I, Melvin Gagerman, certify that:

I have reviewed this quarterly report on Form 10-Q of Aura Systems, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: September 18, 2017

	By:	/s/ Melvin Gagerman
		Melvin Gagerman
		Chief Executive Officer
		(Principal Executive Officer)

EX-31.2 3 f10q0516ex31-2_aurasystem.htm CERTIFICATION

Exhibit 31.2

CERTIFICATION

I, Melvin Gagerman, certify that:

I have reviewed this quarterly report on Form 10-Q of Aura Systems, Inc.;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: September 18, 2017

	By:	/s/ Melvin Gagerman
		Melvin Gagerman
		Acting Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1 4 f10q0516ex32-1_aurasystem.htm CERTIFICATION

Exhibit 32.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q for the period ended May 31, 2016 of Aura Systems, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Melvin Gagerman, Chief Executive Officer and Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the periods presented in the Report.

By:

/s/ Melvin Gagerman

Melvin Gagerman

Chief Executive Officer and

Acting Chief Financial Officer

Date: September 18, 2017

EX-101.INS 5 ausi-20160531.xml XBRL INSTANCE FILE 0000826253 ausi:UnsecuredConvertiblePromissoryNoteMember 2012-08-10 0000826253 ausi:UnsecuredConvertiblePromissoryNoteMember 2012-08-01 2012-08-10 0000826253 ausi:UnsecuredConvertiblePromissoryNoteMember 2012-10-02 0000826253 ausi:UnsecuredConvertiblePromissoryNoteMember 2012-10-01 2012-10-02 0000826253 ausi:KenmontCapitalPartnersMember us-gaap:ConvertibleNotesPayableMember 2013-05-07 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2013-05-07 0000826253 ausi:HolderMember us-gaap:ConvertibleNotesPayableMember 2013-05-07 0000826253 us-gaap:ConvertibleNotesPayableMember us-gaap:WarrantMember 2013-05-07 0000826253 ausi:KenmontCapitalPartnersMember us-gaap:ConvertibleNotesPayableMember 2013-05-01 2013-05-07 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2013-05-01 2013-05-07 0000826253 us-gaap:ConvertibleNotesPayableMember us-gaap:WarrantMember 2013-05-01 2013-05-07 0000826253 ausi:HolderMember us-gaap:ConvertibleNotesPayableMember 2013-06-20 0000826253 ausi:HolderMember us-gaap:BoardOfDirectorsChairmanMember us-gaap:ConvertibleNotesPayableMember 2013-06-20 0000826253 ausi:HolderMember us-gaap:ConvertibleNotesPayableMember 2013-06-19 2013-06-20 0000826253 ausi:HolderMember us-gaap:BoardOfDirectorsChairmanMember us-gaap:ConvertibleNotesPayableMember 2013-08-19 0000826253 ausi:HolderMember us-gaap:BoardOfDirectorsChairmanMember us-gaap:ConvertibleNotesPayableMember 2013-08-18 2013-08-19 0000826253 2015-02-28 0000826253 2015-03-01 2015-05-31 0000826253 us-gaap:CustomerConcentrationRiskMember 2015-03-01 2015-05-31 0000826253 ausi:SignificantCustomer1Member 2015-03-01 2015-05-31 0000826253 ausi:SignificantCustomer2Member 2015-03-01 2015-05-31 0000826253 ausi:SignificantCustomer3Member 2015-03-01 2015-05-31 0000826253 us-gaap:DirectorMember 2015-03-01 2015-05-31 0000826253 country:US 2015-03-01 2015-05-31 0000826253 country:CA 2015-03-01 2015-05-31 0000826253 us-gaap:EuropeMember 2015-03-01 2015-05-31 0000826253 us-gaap:AsiaMember 2015-03-01 2015-05-31 0000826253 us-gaap:AllOtherSegmentsMember 2015-03-01 2015-05-31 0000826253 2015-05-31 0000826253 ausi:SignificantCustomer1Member 2015-05-31 0000826253 ausi:SignificantCustomer2Member 2015-05-31 0000826253 ausi:SignificantCustomer3Member 2015-05-31 0000826253 ausi:DirectorOneMember 2015-03-01 2016-02-29 0000826253 2016-02-29 0000826253 us-gaap:UnsecuredDebtMember us-gaap:DirectorMember 2016-02-29 0000826253 us-gaap:DirectorMember ausi:AccruedInterestMember 2016-02-29 0000826253 ausi:NotesPayableMember 2016-02-29 0000826253 us-gaap:ConvertibleNotesPayableMember 2016-02-29 0000826253 ausi:ConvertibleOneMember 2016-02-29 0000826253 ausi:ConvertibleTwoMember 2016-02-29 0000826253 ausi:ConvertibleThreeMember 2016-02-29 0000826253 ausi:ConvertibleFourMember 2016-02-29 0000826253 us-gaap:UnsecuredDebtMember ausi:DirectorOneMember 2016-02-29 0000826253 ausi:AccruedInterestMember ausi:DirectorOneMember 2016-02-29 0000826253 ausi:TwoThousandSixPalnMember 2016-02-29 0000826253 us-gaap:WarrantMember 2016-02-29 0000826253 us-gaap:WarrantMember us-gaap:MaximumMember 2016-02-29 0000826253 us-gaap:WarrantMember us-gaap:MinimumMember 2016-02-29 0000826253 ausi:TwoThousandSixPalnMember us-gaap:MaximumMember 2016-02-29 0000826253 ausi:TwoThousandSixPalnMember us-gaap:MinimumMember 2016-02-29 0000826253 2016-03-01 2016-05-31 0000826253 us-gaap:DirectorMember 2016-03-01 2016-05-31 0000826253 country:US 2016-03-01 2016-05-31 0000826253 country:CA 2016-03-01 2016-05-31 0000826253 us-gaap:EuropeMember 2016-03-01 2016-05-31 0000826253 us-gaap:AsiaMember 2016-03-01 2016-05-31 0000826253 us-gaap:AllOtherSegmentsMember 2016-03-01 2016-05-31 0000826253 ausi:DirectorOneMember 2016-03-01 2016-05-31 0000826253 us-gaap:ConvertibleNotesPayableMember 2016-03-01 2016-05-31 0000826253 ausi:ConvertibleOneMember 2016-03-01 2016-05-31 0000826253 ausi:ConvertibleTwoMember 2016-03-01 2016-05-31 0000826253 ausi:ConvertibleThreeMember 2016-03-01 2016-05-31 0000826253 ausi:ConvertibleFourMember 2016-03-01 2016-05-31 0000826253 ausi:TwoThousandSixPalnMember 2016-03-01 2016-05-31 0000826253 us-gaap:WarrantMember 2016-03-01 2016-05-31 0000826253 us-gaap:WarrantMember us-gaap:MaximumMember 2016-03-01 2016-05-31 0000826253 us-gaap:WarrantMember us-gaap:MinimumMember 2016-03-01 2016-05-31 0000826253 us-gaap:ChiefExecutiveOfficerMember 2016-03-01 2016-05-31 0000826253 ausi:RangeOfExercisePricesMember 2016-03-01 2016-05-31 0000826253 ausi:RangeOfExercisePricesOneMember 2016-03-01 2016-05-31 0000826253 ausi:RangeOfExercisePricesTwoMember 2016-03-01 2016-05-31 0000826253 ausi:RangeOfExercisePricesThreeMember 2016-03-01 2016-05-31 0000826253 ausi:RangeOfExercisePricesFourMember 2016-03-01 2016-05-31 0000826253 ausi:RangeOfExercisePricesFiveMember 2016-03-01 2016-05-31 0000826253 2016-05-31 0000826253 us-gaap:UnsecuredDebtMember us-gaap:DirectorMember 2016-05-31 0000826253 us-gaap:DirectorMember ausi:AccruedInterestMember 2016-05-31 0000826253 ausi:NotesPayableMember 2016-05-31 0000826253 us-gaap:ConvertibleNotesPayableMember 2016-05-31 0000826253 ausi:ConvertibleOneMember 2016-05-31 0000826253 ausi:ConvertibleTwoMember 2016-05-31 0000826253 ausi:ConvertibleThreeMember 2016-05-31 0000826253 ausi:ConvertibleFourMember 2016-05-31 0000826253 us-gaap:UnsecuredDebtMember ausi:DirectorOneMember 2016-05-31 0000826253 ausi:AccruedInterestMember ausi:DirectorOneMember 2016-05-31 0000826253 ausi:TwoThousandSixPalnMember 2016-05-31 0000826253 us-gaap:WarrantMember 2016-05-31 0000826253 us-gaap:WarrantMember us-gaap:MaximumMember 2016-05-31 0000826253 us-gaap:WarrantMember us-gaap:MinimumMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesOneMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesTwoMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesThreeMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesFourMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesFiveMember 2016-05-31 0000826253 us-gaap:ChiefExecutiveOfficerMember ausi:AccruedInterestMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesMember us-gaap:MaximumMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesMember us-gaap:MinimumMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesThreeMember us-gaap:MaximumMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesThreeMember us-gaap:MinimumMember 2016-05-31 0000826253 us-gaap:ChiefExecutiveOfficerMember us-gaap:UnsecuredDebtMember 2016-05-31 0000826253 ausi:NotesPayableMember us-gaap:MinimumMember 2016-05-31 0000826253 ausi:NotesPayableMember us-gaap:MaximumMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesFourMember us-gaap:MaximumMember 2016-05-31 0000826253 ausi:RangeOfExercisePricesFourMember us-gaap:MinimumMember 2016-05-31 0000826253 ausi:DirectorOneMember us-gaap:ConvertibleNotesPayableMember 2016-05-31 0000826253 us-gaap:BoardOfDirectorsChairmanMember ausi:JulyTwoZeroOneSevenMember 2016-05-31 0000826253 ausi:TwoThousandSixPalnMember us-gaap:MaximumMember 2016-05-31 0000826253 ausi:TwoThousandSixPalnMember us-gaap:MinimumMember 2016-05-31 0000826253 us-gaap:SubsequentEventMember ausi:DebtRefinancingAgreementMember 2017-01-24 0000826253 us-gaap:SubsequentEventMember ausi:DebtRefinancingAgreementMember 2017-01-05 2017-01-24 0000826253 us-gaap:SubsequentEventMember ausi:JointVentureAgreementMember 2017-01-27 0000826253 us-gaap:SubsequentEventMember ausi:ChineseMember 2017-01-27 0000826253 us-gaap:SubsequentEventMember ausi:JointVentureAgreementMember 2017-01-02 2017-01-27 0000826253 us-gaap:SubsequentEventMember ausi:ChineseMember 2017-01-02 2017-01-27 0000826253 us-gaap:SubsequentEventMember 2017-01-30 0000826253 us-gaap:SubsequentEventMember 2017-01-13 2017-01-30 0000826253 2017-08-31 xbrli:shares iso4217:USD iso4217:USDxbrli:shares utr:sqft xbrli:pure ausi:Notes ausi:Segments ausi:Individual AURA SYSTEMS INC 0000826253 false AUSI --02-28 10-Q 2016-05-31 2017 Q1 Smaller Reporting Company 126608391

34855

53115

22175

357311

2115

16282

9677

40572

366988

90213

130785

366988

1823776

2293268

5389883

5587418

641751

3927468

4182468

2720700

26869911

14880372

7680164

3418738

784934

27356841

14903252

8054541

3424064

867234

25748

82000

23704

41373489

42782446

1366922

1389337

2560425

2676913

796063

1880851

45300836

46848696

11304

11399

410404692

410499597

-455586047

-456992704

-45170051

-46481708

130785

366988

0.0001

150000000

113041432

113951432

113041432

113951432

106327

73562

32765

137487

33788

1455689

616977

1593176

650765

-1560411

-650765

740700

827947

1606884

70288

59500

1767

-681200

-755892

-2241611

-1406657

-0.02

-0.01

113041432

113848171

713

310723

137583

342020

175793

235985

63622

667118

64110

70288

-54352

-2115

-39623

-96819

1767075

1215829

-315740

-98072

24000

405000

310000

28208

334000

433208

18260

335136

<div><p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">NOTE 1 – ACCOUNTING POLICIES<p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Accounting principles<p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In the opinion of management, the accompanying balance sheets and related interim statements of income and comprehensive income, and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s annual report on Form 10-K for the year ended February 29, 2016 filed on September 18, 2017 with the U.S. Securities and Exchange Commission.<p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Estimates<p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Recently Issued Accounting Pronouncements <p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03, Interest–Imputation of Interest (Subtopic 835-30) (“ASU 2015-03”), which changes the presentation of debt issuance costs in financial statements. ASU 2015-03 requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. It is effective for annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The new guidance will be applied retrospectively to each prior period presented. The Company is currently in the process of evaluating the impact of adoption of ASU 2015-03 on its balance sheets.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In January 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) 2016-01, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affect the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017, and upon adoption, an entity should apply the amendments by means of a cumulative-effect adjustment to the balance sheet at the beginning of the first reporting period in which the guidance is effective. Early adoption is not permitted except for the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income. The Company is currently evaluating the impact of adopting this guidance.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Topic 842 affects any entity that enters into a lease, with some specified scope exemptions. The guidance in this Update supersedes Topic 840, Leases. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For public companies, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We are currently evaluating the impact of adopting ASU No. 2016-02 on our financial statements.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) that clarifies how to apply revenue recognition guidance related to whether an entity is a principal or an agent. ASU 2016-08 clarifies that the analysis must focus on whether the entity has control of the goods or services before they are transferred to the customer and provides additional guidance about how to apply the control principle when services are provided and when goods or services are combined with other goods or services. The effective date for ASU 2016-08 is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years. The Company has not yet determined the impact of ASU 2016-08 on its financial statements.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation, or ASU No. 2016-09. The areas for simplification in this Update involve several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public entities, the amendments in this Update are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted in any interim or annual period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of the amendments in the same period. Amendments related to the timing of when excess tax benefits are recognized, minimum statutory withholding requirements, forfeitures, and intrinsic value should be applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of the beginning of the period in which the guidance is adopted. Amendments related to the presentation of employee taxes paid on the statement of cash flows when an employer withholds shares to meet the minimum statutory withholding requirement should be applied retrospectively. Amendments requiring recognition of excess tax benefits and tax deficiencies in the income statement and the practical expedient for estimating expected term should be applied prospectively. An entity may elect to apply the amendments related to the presentation of excess tax benefits on the statement of cash flows using either a prospective transition method or a retrospective transition method. We are currently evaluating the impact of adopting ASU No. 2016-09 on our financial statements.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which provides further guidance on identifying performance obligations and improves the operability and understandability of licensing implementation guidance. The effective date for ASU 2016-10 is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years.  In May 2016, the FASB issued ASU 2016-12 “Revenue from Contracts with Customers (Topic 606) - Narrow-Scope Improvements and Practical Expedients,” which amends the guidance on transition, collectability, non-cash consideration, and the presentation of sales and other similar taxes. ASU 2016-12 clarifies that, for a contract to be considered completed at transition, all (or substantially all) of the revenue must have been recognized under legacy GAAP. In addition, ASU 2016-12 clarifies how an entity should evaluate the collectability threshold and when an entity can recognize nonrefundable consideration received as revenue if an arrangement does not meet the standard’s contract criteria. The standard allows for both retrospective and modified retrospective methods of adoption. The Company has not yet determined the impact of ASU 2016-10 on its financial statements.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Statements," which requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2019 (fiscal year 2021 for the Company). The Company has not yet determined the potential effects of the adoption of ASU 2016-13 on its Financial Statements.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In August 2016, the FASB issued ASU 2016-15, "Classification of Certain Cash Receipts and Cash Payments," which aims to eliminate diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. ASU 2016-15 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2017 (fiscal year 2019 for the Company). The Company has not yet determined the potential effects of the adoption of ASU 2016-15 on its Financial Statements.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;">Reclassifications<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Certain reclassifications have been made to the comparative financial statements to conform to the current period presentation.</div>

<div><p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">NOTE 3 – INVENTORIES<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Inventories, stated at the lower of cost (first in first out), or market consisted of the following:<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">May 31, 2016</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">February 29, 2016</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 790px; text-align: left; font-stretch: normal;">Raw materials</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 94px; text-align: right; font-stretch: normal;">1,872,720</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 93.33px; text-align: right; font-stretch: normal;">1,858,347</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">Finished goods</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">1,568,188</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">1,558,554</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">3,440,908</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">3,416,901</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">Inventory reserve</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(3,440,908</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(3,416,901</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">0</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">0</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company has not operated and therefore has not produced product since late 2015. As a result, while the Company believes that a significant portion of the inventory has value, we are unable to substantiate its demand and market value and as a result have elected to reserve it in its entirety as of May 31, 2016 and February 29, 2016.</div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">NOTE 4 – OTHER CURRENT ASSETS<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Other assets of $9,677 and $16,283 are comprised of vendor advances of $2,895 and $16,283 as of May 31, 2016 and February 29, 2016.</div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">NOTE 5 – PROPERTY, PLANT, AND EQUIPMENT<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Property, plant, and equipment consisted of the following:<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">May 31, 2016</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">February 29, 2016</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 790px; text-align: left; font-stretch: normal;">Machinery and equipment</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 94px; text-align: right; font-stretch: normal;">964,111</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 93.33px; text-align: right; font-stretch: normal;">964,111</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">Furniture and fixtures</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">163,302</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">163,302</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,127,413</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,127,413</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">Less accumulated depreciation</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(1,127,413</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(1,127,413</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">Property, plant and equipment, net</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">0</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">0</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">  <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Depreciation expense was $0 and $713 for the Three months ended May 31, 2016 and May 21, 2015, respectively.</div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;">NOTE 7 – ACCRUED EXPENSES<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Accrued expenses consisted of the following:<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">May 31, 2016</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">February 29, 2016</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;" colspan="2"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;" colspan="2"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 790px; text-align: left; font-stretch: normal;">Accrued payroll and related expenses</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 94px; text-align: right; font-stretch: normal;">3,146,841</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 93.33px; text-align: right; font-stretch: normal;">3,148,841</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Accrued rent</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">214,774</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">218,025</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">Accrued interest</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">2,135,804</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,933,017</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">Other</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">90,000</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">90,000</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0px; padding-right: 0px; padding-bottom: 4pt; padding-left: 0.125in; font-stretch: normal;">Total</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">5,587,419</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">5,389,883</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Accrued payroll and related expenses consists of salaries and vacation time accrued but not paid to employees due to our lack of financial resources.</div>

<div><p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">NOTE 8 – SHAREHOLDERS’ EQUITY<p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Common Stock<p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the three months ended May 31, 2016, we issued 950,000 shares of common stock were issued in settlement for a note payable balance $150,000 plus accrued interest of $15,288.<p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the three months ended May 31, 2015, we did not issue any shares of common stock.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">   <p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Employee Stock Options<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the Three months ended May 31, 2016, there were no stock options granted to employees.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In September, 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan. Activity in this plan is as follows:<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">2006 Plan</td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted- Average Exercise Price</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number of Options</td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 665.33px;">Outstanding, February 29, 2016</td><td style="width: 10.66px;"> </td><td style="width: 10.66px; text-align: left;"></td><td style="width: 94px; text-align: right;">$0.75-$1.00</td><td style="width: 10.66px; text-align: left;"> </td><td style="width: 10.66px;"> </td><td style="width: 10.66px; text-align: left;">$</td><td style="width: 93.33px; text-align: right;">0.00</td><td style="width: 10px; text-align: left;"> </td><td style="width: 10px;"> </td><td style="width: 10px; text-align: left;"> </td><td style="width: 93.33px; text-align: right;">7,224,000</td><td style="width: 10px; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td>Cancelled</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 1.5pt;">Granted</td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt;">Outstanding, May 31, 2016</td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"></td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$0.75-$1.00</td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">0.00</td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">7,224,000</td><td style="text-align: left; padding-bottom: 1.5pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The exercise prices for the options outstanding at May 31, 2016, and information relating to these options is as follows:<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="11">Options Outstanding</td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="9">Exercisable Options</td></tr><tr style="vertical-align: bottom;"><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">Range of Exercise Price</td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">Weighted Average Remaining  Life</td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">Weighted Average Remaining Life</td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 146px; text-align: center;"> $0.75-$1.00</td><td style="width: 10.66px;"> </td><td style="width: 10.66px; text-align: left;"> </td><td style="width: 125.33px; text-align: right;">7,224,000</td><td style="width: 10.66px; text-align: left;"> </td><td style="width: 10.66px;"> </td><td style="width: 146px; text-align: right;">3.75 years</td><td style="width: 10.66px;"> </td><td style="width: 10.66px; text-align: left;">$</td><td style="width: 114.66px; text-align: right;">0.79</td><td style="width: 10.66px; text-align: left;"> </td><td style="width: 10px;"> </td><td style="width: 134.66px; text-align: right;">3.75 years</td><td style="width: 10px;"> </td><td style="width: 10px; text-align: left;"> </td><td style="width: 114px; text-align: right;">7,224,000</td><td style="width: 10px; text-align: left;"> </td><td style="width: 10px;"> </td><td style="width: 10px; text-align: left;">$</td><td style="width: 114px; text-align: right;">0.79</td><td style="width: 10px; text-align: left;"> </td></tr></table><p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Warrants<p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Activity in issued and outstanding warrants is as follows:<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Number of Shares</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Exercise Prices</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 790px; font-stretch: normal;">Outstanding, February 29, 2016</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 94px; text-align: right; font-stretch: normal;">36,726,208</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 93.33px; text-align: right; font-stretch: normal;">$0.10-$1.50</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Granted</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">-</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">-</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercised</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">-</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">-</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;">Cancelled</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(1,657,188</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">)</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">$1.00-$1.50</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;">Outstanding, May 31, 2016</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">35,069,020</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$0.10-$1.50</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">There were no warrants issued in the three months ended May 31,2016.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The exercise prices for the warrants outstanding at May 31, 2016, and information relating to these warrants is as follows:<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">Range of Exercise Prices</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Stock Warrants Outstanding</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Stock Warrants Exercisable</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">Weighted- Average Remaining Contractual Life</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Weighted- Average  Exercise Price of Warrants Outstanding</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Weighted- Average Exercise Price of Warrants Exercisable</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Intrinsic Value</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 146px; text-align: center; font-stretch: normal;">$0.10-$0.75</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125.33px; text-align: right; font-stretch: normal;">19,481,012</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125.33px; text-align: right; font-stretch: normal;">19,481,012</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 135.33px; text-align: right; font-stretch: normal;">58 months</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 114px; text-align: right; font-stretch: normal;">0.56</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 114px; text-align: right; font-stretch: normal;">0.56</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 114px; text-align: right; font-stretch: normal;">0.00</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">$0.75</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,082,734</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,082,734</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">57 months</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.75</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.75</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.00</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">$0.75</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,000,000</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1,000,000</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">47 months</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.75</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.75</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.00</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">$0.75-$1.00</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">5,990,275</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">5,990,275</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">42 months</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.77</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.77</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.00</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;">$1.00-$1.25</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">795,000</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">795,000</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">4 months</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1.05</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1.05</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.00</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; font-stretch: normal;">$1.00</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">6,719,999</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">6,719,999</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 1.5pt; font-stretch: normal;">3 months</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1.00</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">1.00</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">0.00</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">35,069,020</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">35,069,020</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></div>

<div><p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0px; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">NOTE 10 – SEGMENT INFORMATION<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">We are a United States based company providing advanced technology products to various industries. The principal markets for our products are North America, Europe, and Asia. All of our operating long-lived assets are located in the United States. We operate in one segment.<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Total net revenues from customer geographical segments are as follows for the three months ended May 31, 2016 and 2015:<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="color: black;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2016</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2015</td><td style="color: black; padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="color: black;"> </td><td style="color: black;"> </td><td style="text-align: right; color: black;" colspan="2"> </td><td style="color: black;"> </td><td style="color: black;"> </td><td style="text-align: right; color: black;" colspan="2"> </td><td style="color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left; color: black;">United States</td><td style="width: 16px; color: black;"> </td><td style="width: 16px; text-align: left; color: black;">$</td><td style="width: 142px; text-align: right; color: black;">0</td><td style="width: 16px; text-align: left; color: black;"> </td><td style="width: 15px; color: black;"> </td><td style="width: 15px; text-align: left; color: black;">$</td><td style="width: 141px; text-align: right; color: black;">30,124</td><td style="width: 15px; text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="color: black;">Canada</td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">         </td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">-</td><td style="text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="color: black;">Europe</td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">210</td><td style="text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="color: black;">Asia</td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">20,014</td><td style="text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="color: black; padding-bottom: 1.5pt;">Other</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">55,979</td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="color: black; padding-bottom: 4pt; padding-left: 10pt;">Total</td><td style="color: black; padding-bottom: 4pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">0</td><td style="text-align: left; color: black; padding-bottom: 4pt;"> </td><td style="color: black; padding-bottom: 4pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">106,327</td><td style="text-align: left; color: black; padding-bottom: 4pt;"></td></tr></table></div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">NOTE 11 – SIGNIFICANT CUSTOMERS<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Concentration Risk<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In the three months ended May 31, 2016, we did not have any sales to customers. In the Three months ended May 31, 2015, we sold AuraGen related products to three significant customers whose sales comprised 45%, 32% and 17% of sales, respectively. Net accounts receivable from these customers at May 31, 2015 were $0, $0 and $0 respectively. These customers are not related to or affiliated with us.</div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">NOTE 13 – COMMITMENTS<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Our facilities consist of approximately 20,000 rented square feet in Stanton, California. The Stanton facility is currently being used for small quantity assembly and testing using components that are produced by various suppliers as well as for general offices, engineering and warehousing. The rent for the Stanton facility is $10,000 per month. The facility is not sufficient for our near term anticipated needs and the Company is actively looking for a new facility. The Company arrangements for the Stanton facility are on a month per month rent.</div>

<div><p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Estimates<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</div>

<div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">May 31, 2016</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">February 29, 2016</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;" colspan="2"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;" colspan="2"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 790px; text-align: left; font-stretch: normal;">Demand notes payable, at 10% and 16%</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 94px; text-align: right; font-stretch: normal;">4,182,468</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10.66px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 93.33px; text-align: right; font-stretch: normal;">3,927,468</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 10px; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;">Convertible Promissory Note dated August 10, 2012, due August 10, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 10th of each month with the principal payment due on the maturity date. To-date, the Company has not made any interest payments as set forth in this note.</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">926,024</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">910,488</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;">Convertible Promissory Note dated October 2, 2012, due October 2, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2nd of each month with the principal payment due on the maturity date. To-date, the Company has not made any interest payments as set forth in this note.</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">463,313</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">456,434</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;">Senior secured convertible notes dated May 7, 2013, due May 7, 2014, convertible into shares of our common stock at a price of $0.75 per share. The note was not repaid.</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">2,395,700</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">2,395,700</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;">Senior secured convertible notes dated June 20, 2013, due June 20, 2014, convertible into shares of our common stock at a price of $0.50 per share. The note was not repaid.</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">325,000</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">325,000</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;">Convertible notes dated April thru May, 2016. The notes carry an interest rate of 5% and might be converted into shares of Company’s common stock if the shareholders approve a 7:1 reverse stock split.</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">400,000</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">-</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">8,292,505</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;">8,015,090</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;">Less: Current portion</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">6,903,168</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">6,648,168</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;">Long-term portion</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">1,389,337</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">1,366,922</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"></td></tr></table></div>

<div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; color: black; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; color: black; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="10">Options Outstanding</td><td style="font: 10pt/normal 'times new roman', times, serif; color: black; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="8">Exercisable Options</td><td style="font: 10pt/normal 'times new roman', times, serif; color: black; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; color: black; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; color: black; vertical-align: bottom; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">Range of ExercisePrice</td><td style="font: 10pt/normal 'times new roman', times, serif; color: black; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; color: black; vertical-align: bottom; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Number</td><td style="font: 10pt/normal 'times new roman', times, serif; color: black; padding-bottom: 1.5pt; vertical-align: bottom; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; color: black; vertical-align: bottom; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Weighted Average Remaining Life</td><td style="font: 10pt/normal 'times new roman', times, serif; color: black; padding-bottom: 1.5pt; vertical-align: bottom; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; color: black; vertical-align: bottom; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Weighted Average Exercise Price</td><td style="font: 10pt/normal 'times new roman', times, serif; color: black; padding-bottom: 1.5pt; vertical-align: bottom; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; color: black; vertical-align: bottom; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Weighted Average Remaining Life</td><td style="font: 10pt/normal 'times new roman', times, serif; color: black; padding-bottom: 1.5pt; vertical-align: bottom; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; color: black; vertical-align: bottom; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Number</td><td style="font: 10pt/normal 'times new roman', times, serif; color: black; padding-bottom: 1.5pt; vertical-align: bottom; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; color: black; vertical-align: bottom; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Weighted Average Exercise Price</td><td style="font: 10pt/normal 'times new roman', times, serif; color: black; padding-bottom: 1.5pt; vertical-align: bottom; font-stretch: normal;"> </td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; color: black; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 220px; text-align: center; color: black; vertical-align: bottom; font-stretch: normal;">$0.75-$1.00</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; color: black; border-bottom-color: #ccffcc; border-bottom-width: 1pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; color: black; vertical-align: bottom; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 173px; text-align: center; color: black; vertical-align: bottom; font-stretch: normal;">7,224,000</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; color: black; vertical-align: bottom; border-bottom-color: #ccffcc; border-bottom-width: 1pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; color: black; vertical-align: bottom; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 220px; text-align: center; color: black; vertical-align: bottom; font-stretch: normal;">3.75 years</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; color: black; vertical-align: bottom; border-bottom-color: #ccffcc; border-bottom-width: 1pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; color: black; vertical-align: bottom; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 173px; text-align: right; color: black; vertical-align: bottom; font-stretch: normal;">0.79</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 16px; color: black; vertical-align: bottom; border-bottom-color: #ccffcc; border-bottom-width: 1pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; color: black; vertical-align: bottom; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 235px; text-align: center; color: black; vertical-align: bottom; font-stretch: normal;">3.75 years</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; color: black; vertical-align: bottom; border-bottom-color: #ccffcc; border-bottom-width: 1pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; color: black; vertical-align: bottom; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 172px; text-align: center; color: black; vertical-align: bottom; font-stretch: normal;">7,224,000</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; color: black; vertical-align: bottom; border-bottom-color: #ccffcc; border-bottom-width: 1pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; color: black; vertical-align: bottom; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 172px; text-align: right; color: black; vertical-align: bottom; font-stretch: normal;">0.79</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; color: black; vertical-align: bottom; border-bottom-color: #ccffcc; border-bottom-width: 1pt; border-bottom-style: solid; font-stretch: normal;"> </td></tr></table></div>

<div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">Range of Exercise Prices</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Stock Warrants Outstanding</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Stock Warrants Exercisable</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">Weighted-Average Remaining Contractual Life</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted-Average Exercise Price of Warrants Outstanding</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted-Average Exercise Price of Warrants Exercisable</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Intrinsic Value</td><td style="color: black; padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 189px; text-align: center; color: black;">$0.10-$0.75</td><td style="width: 16px; text-align: left; color: black;"> </td><td style="width: 16px; color: black;"> </td><td style="width: 16px; text-align: left; color: black;"> </td><td style="width: 189px; text-align: right; color: black;">19,481,012</td><td style="width: 16px; text-align: left; color: black;"> </td><td style="width: 16px; color: black;"> </td><td style="width: 16px; text-align: left; color: black;"> </td><td style="width: 189px; text-align: right; color: black;">19,481,012</td><td style="width: 16px; text-align: left; color: black;"> </td><td style="width: 16px; color: black;"> </td><td style="width: 220px; text-align: center; color: black;">58 months</td><td style="width: 16px; color: black;"> </td><td style="width: 15px; text-align: left; color: black;">$</td><td style="width: 172px; text-align: right; color: black;">0.56</td><td style="width: 15px; text-align: left; color: black;"> </td><td style="width: 15px; color: black;"> </td><td style="width: 15px; text-align: left; color: black;">$</td><td style="width: 172px; text-align: right; color: black;">0.56</td><td style="width: 15px; text-align: left; color: black;"> </td><td style="width: 15px; color: black;"> </td><td style="width: 15px; text-align: left; color: black;">$</td><td style="width: 172px; text-align: right; color: black;">0.00</td><td style="width: 15px; text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; color: black;">$0.75</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">1,082,734</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">1,082,734</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: center; color: black;">57 months</td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.75</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.75</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.00</td><td style="text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: center; color: black;">$0.75</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">1,000,000</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">1,000,000</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: center; color: black;">47 months</td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.75</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.75</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.00</td><td style="text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; color: black;">$0.75-$1.00</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">5,990,275</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">5,990,275</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: center; color: black;">42 months</td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.77</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.77</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.00</td><td style="text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: center; color: black;">$1.00-$1.25</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">795,000</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">795,000</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: center; color: black;">4 months</td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">1.05</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">1.05</td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.00</td><td style="text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; color: black;">$1.00</td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">6,719,999</td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">6,719,999</td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; padding-bottom: 1.5pt;">3 months</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">1.00</td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">1.00</td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black;">$</td><td style="text-align: right; color: black;">0.00</td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: center; color: black;"> </td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; color: black;"> </td><td style="text-align: left; color: black; padding-bottom: 4pt;"> </td><td style="color: black; padding-bottom: 4pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">35,069,020</td><td style="text-align: left; color: black; padding-bottom: 4pt;"> </td><td style="color: black; padding-bottom: 4pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">35,069,020</td><td style="text-align: left; color: black; padding-bottom: 4pt;"> </td><td style="color: black; padding-bottom: 4pt;"> </td><td style="text-align: center; color: black; padding-bottom: 4pt;"> </td><td style="color: black; padding-bottom: 4pt;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black; padding-bottom: 4pt;"> </td><td style="color: black; padding-bottom: 4pt;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black; padding-bottom: 4pt;"> </td><td style="color: black; padding-bottom: 4pt;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black; padding-bottom: 4pt;"> </td></tr></table></div>

<table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="color: black;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2016</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: center; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2015</td><td style="color: black; padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="color: black;"> </td><td style="color: black;"> </td><td style="text-align: right; color: black;" colspan="2"> </td><td style="color: black;"> </td><td style="color: black;"> </td><td style="text-align: right; color: black;" colspan="2"> </td><td style="color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left; color: black;">United States</td><td style="width: 16px; color: black;"> </td><td style="width: 16px; text-align: left; color: black;">$</td><td style="width: 142px; text-align: right; color: black;">0</td><td style="width: 16px; text-align: left; color: black;"> </td><td style="width: 15px; color: black;"> </td><td style="width: 15px; text-align: left; color: black;">$</td><td style="width: 141px; text-align: right; color: black;">30,124</td><td style="width: 15px; text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="color: black;">Canada</td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">         </td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">-</td><td style="text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="color: black;">Europe</td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">210</td><td style="text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="color: black;">Asia</td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="color: black;"> </td><td style="text-align: left; color: black;"> </td><td style="text-align: right; color: black;">20,014</td><td style="text-align: left; color: black;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="color: black; padding-bottom: 1.5pt;">Other</td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td><td style="color: black; padding-bottom: 1.5pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">55,979</td><td style="text-align: left; color: black; padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="color: black; padding-bottom: 4pt; padding-left: 10pt;">Total</td><td style="color: black; padding-bottom: 4pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">0</td><td style="text-align: left; color: black; padding-bottom: 4pt;"> </td><td style="color: black; padding-bottom: 4pt;"> </td><td style="text-align: left; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; color: black; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">106,327</td></tr></table>

45000

1858347

1872720

1558554

1568188

3416901

3440908

3416901

3440908

16283

2895

964111

163302

1127413

3927468

4182468

8015090

910488

456434

2395700

325000

8292505

926024

463313

2395700

325000

400000

14930041

4095700

6648168

6903168

0.07

0.16

0.095

0.07

0.05

0.10

0.16

0.05

2017-08-10

2012-10-02

2017-08-10

2017-10-02

2014-05-07

2014-06-20

0.75

0.50

0.76

0.75

0.50

7:1 reverse stock split.

1389337

1000000

500000

1000000

550000

750000

325000

2500000

1087000

558700

P7Y P7Y P7Y P7Y P7Y

0.75

1.50

0.10

1.50

0.10

1449333

744933

1000000

433334

5000000

4 2

P5Y

P5Y0M0D

P1Y

P4Y

P5Y

The note holder will receive interest on the unpaid principal amount payable monthly in arrears on the tenth day of each calendar month commencing September 10, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year.

The note holder will receive interest on the unpaid principal amount payable monthly in arrears on the second day of each calendar month commencing November 2, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year.

500000

3148841

3146841

218025

214774

1933017

2135804

90000

1.00

0.75

1.00

0.75

7224000

0.75

1.00

7224000

P3Y9M0D

0.79

P3Y9M0D

7224000

0.79

36726208

35069020

19481012

1082734

1000000

5990275

795000

6719999

22000000

1657188

1.50 1.00

0.75

1.00

0.75

0.10

1.00

0.75

1.25

1.00

35069020 19481012 1082734 1000000 5990275 795000 6719999

P58M

P57M

P47M

P42M

P4M

P3M

0.56 0.75 0.75 0.77 1.05 1.00 0.56 0.75 0.75 0.77 1.05 1.00

0.00

950000

150000

15288

8890574

0.000

106327

30124

210

20014

55979

0.45

0.32

0.17

0.10

2013-04-05

374378

359762

119149

20000

10000

23872614

11982041

7403705

The stockholders approving a 1 for 7 reverse stock split within one year of entering this agreement and the remaining may be converted at any time thereafter post reverse split. In the absence of the approval within one year, this agreement will become null and void. The Company has elected to continue to accrue interest on this agreement until such time as the 1 for 7 reverse stock split has been approved.

The Amended Notes bear interest at the rate of 0% until May 1, 2017 and 5% per annum thereafter, subject to reduction to comply with applicable law, and mature in 60 months from the effective date of a 1 for 7 reverse stock split. Upon certain financings, the Company is obligated to make a payment to the holders of the Amended Notes in the amount of 20% of the outstanding Notes. Immediately upon the effectiveness of a 1 for 7 reverse stock split, 80% of the then-unpaid principal of and all of the then accrued but unpaid interest on the Amended Notes is automatically converted.

250000

9750000

0.49

0.51

2000000

0.20

10000000

1250000

125000

5400000

EX-101.SCH 6 ausi-20160531.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Balance Sheets (Parenthetical) (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Accounting Policies link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Going Concern link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Other Current Assets link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Property, Plant, and Equipment link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Notes Payable link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Significant Customers link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Related Parties Transactions link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Commitments link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Property, Plant, and Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Inventories (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Other Current Assets (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Property, Plant, and Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Property, Plant, and Equipment (Details Textual) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Notes Payable (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Notes Payable (Details 1) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Notes Payable (Details Textual) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Accrued Expenses (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Shareholders' Equity (Details 1) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Shareholders' Equity (Details 2) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Shareholders' Equity (Details 3) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Shareholders' Equity (Details Textual) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Segment Information (Details) link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Segment Information (Details Textual) link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Significant Customers (Details) link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Related Parties Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Commitments (Details) link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 ausi-20160531_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ausi-20160531_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ausi-20160531_lab.xml XBRL LABEL FILE Document and Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Amendment Flag Trading Symbol Current Fiscal Year End Date Document Type Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Filer Category Entity Common Stock, Shares Outstanding Statement of Financial Position [Abstract] Assets [Abstract] ASSETS Current assets: Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Accounts receivable, net of allowance for doubtful accounts of $50,000 at November 30 and February 28, 2014, respectively Accounts receivable, Other assets Other current assets Assets, Current Total current assets Deposits Assets Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Accounts payable Accrued Liabilities, Current Accrued expenses Total Customer advances Other Notes Payable, Current Notes payable Demand notes payable, at 10% and 16% Notes Payable, Current Convertible note payable and accrued interest-related party, net of discount Convertible Notes Payable, Current Convertible notes payable, net of discount Notes payable and accrued interest- related party Unsecured notes payable and accrued interest- related party Liabilities, Current Total current liabilities Convertible note payable, net of discount Long-term portion Long-term portion Convertible note payable and accrued interest-related party, net of discount Convertible note payable and accrued interest-related party, net of discount Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies Stockholders' deficit: CommonStockValue Common stock, $0.0001 par value; 150,000,000 shares authorized at May 31 and February 28, 2015; 113,951,432 and 113,041,432 issued and outstanding at May 31 and February 28, 2016, respectively Additional paid-in capital Accumulated deficit Stockholders' Equity Attributable to Parent Total stockholders' deficit Liabilities and Equity Total liabilities and stockholders' deficit CommonStockParOrStatedValuePerShare Common stock, par value CommonStockSharesAuthorized Common stock, shares authorized CommonStockSharesIssued Common stock, shares issued Common stock, shares outstanding (in shares) Common stock, shares outstanding Income Statement [Abstract] Sales Revenue, Goods, Net Net Revenues Cost of Goods Sold Cost of goods sold Gross Profit Gross Profit Operating Expenses [Abstract] Operating expenses: Research and Development Expense Engineering, research and development expenses Engineering, research and development expenses Selling, General and Administrative Expense Selling, general and administrative expenses Selling, general and administrative expenses Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other (income) and expense: Interest Expense Interest expense, net Interest Interest expense, net Gains (Losses) on Extinguishment of Debt, before Write off of Deferred Debt Issuance Cost Gain on debt settlement Gain on debt settlement Other Nonoperating Income (Expense) Other (income) expense, net Other income, net Nonoperating Income (Expense) Total other (income) expense Total other (income) expense Net Income (Loss) Attributable to Parent Incurred losses Net Loss Net Loss Net Loss Earnings Per Share, Basic and Diluted Total basic and diluted loss per share Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average shares used to compute basic and diluted loss per share Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flow from operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile Net loss to net cash used in operating activities Depreciation Depreciation Expense Depreciation expense Amortization of debt discount Amortization of debt discount Gains (Losses) on Extinguishment of Debt Gain on debt settlement Increase (Decrease) in Receivables [Abstract] (Increase) decrease in: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Other Current Assets Other current assets and deposit Increase (Decrease) in Accounts Payable [Abstract] Increase (decrease) in: Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable, customer deposit and accrued expenses Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash flows from operating activities Net cash used in operations Net Cash Provided by (Used in) Financing Activities [Abstract] Financing activities: Proceeds from Convertible Debt Proceeds from convertible notes payable Proceeds from Notes Payable Proceeds from notes payable-net Proceeds from Related Party Debt Proceeds from notes payable-related party, net Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities: Cash and Cash Equivalents, Period Increase (Decrease) Net increase (decrease) in cash & cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental disclosures of cash flow information Cash paid during the period for: [Abstract] Cash paid during the period for: Interest Paid Interest Income Taxes Paid Income taxes Accounting Policies [Abstract] Accounting Policies [Abstract] Accounting Policies [Abstract] Significant Accounting Policies [Text Block] ACCOUNTING POLICIES Going Concern [Abstract] GOING CONCERN [Text Block] GOING CONCERN The entire disclosure if there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Inventories [Abstract] Inventory Disclosure [Text Block] INVENTORIES Other Current Assets [Abstract] Other Assets Disclosure [Text Block] OTHER CURRENT ASSETS Property, Plant, and Equipment [Abstract] Property, Plant and Equipment Disclosure [Text Block] PROPERTY, PLANT, AND EQUIPMENT Notes Payable [Abstract] Debt Disclosure [Text Block] NOTES PAYABLE Accrued Expenses [Abstract] Accounts Payable and Accrued Liabilities Disclosure [Text Block] ACCRUED EXPENSES Shareholders' Equity [Abstract] Stockholders' Equity Note Disclosure [Text Block] SHAREHOLDERS' EQUITY Income Taxes [Abstract] Income Tax Disclosure [Text Block] INCOME TAXES Segment Information [Abstract] Segment Reporting Disclosure [Text Block] SEGMENT INFORMATION Significant Customers [Abstract] Concentration Risk Disclosure [Text Block] SIGNIFICANT CUSTOMERS Related Parties Transactions [Abstract] RELATED PARTIES TRANSACTIONS Commitments [Abstract] Commitments and Contingencies Disclosure [Text Block] COMMITMENTS Subsequent Events [Abstract] Subsequent Events [Text Block] SUBSEQUENT EVENTS Estimates Recently Issued Accounting Pronouncements Reclassifications Schedule of Inventory, Current [Table Text Block] Schedule of inventories, stated at the lower of cost Property, plant and equipment Schedule of property, plant, and equipment Schedule of Debt [Table Text Block] Schedule of notes payable Schedule of future maturities of notes payable Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Stock option activity Schedule of 2006 employee stock option plan Exercise price of options outstanding and options information Schedule of exercise price options outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of activity in issued and outstanding warrants Schedule of Share Based Compensation Shares Authorized Under Warrants by Exercise Price Range [Table Text Block] Schedule of exercise prices warrants outstanding Exercise prices for the warrants outstanding and warrant information Tabular disclosure of warrant exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under warrant, weighted average exercise price and remaining contractual terms. Reconciliation of Revenue from Segments to Consolidated [Table Text Block] Summary of revenues from customer geographical segments Going Concern Textual [Abstract] Going Concern (Textual) Area of Land Area of land Inventory, Raw Materials, Gross Raw materials Inventory, Finished Goods, Gross Finished goods Inventory, Gross Inventory gross Inventory Valuation Reserves Inventory reserve Inventory reserve Inventory, Net Current portion Inventory net Other Current Assets Textual [Abstract] Other Current Assets (Textual) Advances on Inventory Purchases Vendor advances Machinery and Equipment, Gross Machinery and equipment Furniture and Fixtures, Gross Furniture and fixtures Property, Plant and Equipment, Gross Property, plant and equipment, gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less accumulated depreciation Property, Plant and Equipment, Net Property, plant, and equipment, net Property Plant And Equipment Textual [Abstract] Property, Plant, and Equipment (Textual) Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Notes Payable [Member] Notes Payable [Member] Demand notes payable [Member] Notes payable. Convertible Notes Payable [Member] Convertible Secured Notes [Member] Convertible Promissory Note dated August 10, 2012 [Member] Convertible One [Member] Convertible One [Member] Convertible Promissory Note dated October 2, 2012 [Member] Convertible one. Convertible Two [Member] Senior secured convertible notes dated May 7, 2013 [Member] Convertible Two [Member] Convertible two. Convertible Three [Member] Senior secured convertible notes dated June 20, 2013 [Member] Convertible Three [Member] Convertible three. Convertible Four [Member] Convertible notes dated April thru May, 2016 [Member] Convertible Four [Member] Convertible four. Debt Instrument [Line Items] Notes Payable Demand notes payable Notes payable current and long-term portion Convertible Notes Payable Convertible notes payable Convertible note Long-term Debt, Current Maturities Less: Current portion Less: Current portion Range [Axis] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Debt Instrument, Interest Rate, Stated Percentage Notes payable interest rate Interest rate Due date Due date of notes Debt Instrument, Convertible, Conversion Price Conversion price per share of notes payable Stockholders' Equity Note, Stock Split Reverse stock split Maturities of Note Payable Debt [Abstract] Year Ending February 28 Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 2017 Long-term Debt Total Kenmont Capital Partners [Member] Kenmont Capital Partners [Member] Kenmont Capital Partners. Lpd Investments [Member] LPD Investments [Member] Lpd Investments [Member] LPD Investments. Holder [Member] Holder [Member] Holder. Unsecured Convertible Promissory Note [Member] Unsecured Convertible Promissory Note [Member] Unsecured convertible promissory note. Title of Individual [Axis] Relationship to Entity [Domain] Board of Directors Chairman [Member] Board of Directors [Member] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Equity Components [Axis] Equity Component [Domain] Warrant [Member] Warrants [Member] Notes Payable Textual [Abstract] Notes Payable (Textual) Debt Conversion, Original Debt, Amount Pre conversion debt principal amount Principal value of convertible notes Debt amount Principal value of convertible notes Term of warrant Term of warrant Period when holder have a right to buy the shares by exercising the warrant. Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per common share under warrant one (in dollars per share) Exercise Prices, Outstanding Exercise Prices, Outstanding Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of common shares entitlement on exercise of warrant one (in shares) Number of common shares entitlement on exercise of warrant one (in shares) Number Of Notes Payable To Transferred Number of notes payable to transferred Represents the number of notes payable to transfer. Debt Instrument, Term Notes maturity date, term New debt agreement, term Debt Instrument, Description Description of convertible promissory note Notepayableconverted Conversion to demand note payable It represent demand notes payable converted for the reporting period. Accrued payroll and related expenses Accrued payroll and related expenses Accrued rent Accrued rent Accrued interest Accrued interest Other Other Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] EX-101.PRE 10 ausi-20160531_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	May 31, 2016	Aug. 31, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	AURA SYSTEMS INC
Entity Central Index Key	0000826253
Amendment Flag	false
Trading Symbol	AUSI
Current Fiscal Year End Date	--02-28
Document Type	10-Q
Document Period End Date	May 31, 2016
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		126,608,391

XML 12 R2.htm IDEA: XBRL DOCUMENT

Balance Sheets (Unaudited) - USD ($)	May 31, 2016	Feb. 29, 2016
Current assets:
Cash and cash equivalents	$ 357,311	$ 22,175
Accounts receivable,		2,115
Other current assets	9,677	16,282
Total current assets	366,988	40,572
Deposits		90,213
Total assets	366,988	130,785
Current liabilities:
Accounts payable	2,293,268	1,823,776
Accrued expenses	5,587,418	5,389,883
Customer advances	641,751	641,751
Notes payable	4,182,468	3,927,468
Convertible note payable and accrued interest-related party, net of discount
Convertible notes payable, net of discount	2,720,700	2,720,700
Notes payable and accrued interest- related party	27,356,841	26,869,911
Total current liabilities	42,782,446	41,373,489
Convertible note payable, net of discount	1,389,337	1,366,922
Convertible note payable and accrued interest-related party, net of discount	2,676,913	2,560,425
Total liabilities	46,848,696	45,300,836
Commitments and contingencies
Stockholders' deficit:
Common stock, $0.0001 par value; 150,000,000 shares authorized at May 31 and February 28, 2015; 113,951,432 and 113,041,432 issued and outstanding at May 31 and February 28, 2016, respectively	11,399	11,304
Additional paid-in capital	410,499,597	410,404,692
Accumulated deficit	(456,992,704)	(455,586,047)
Total stockholders' deficit	(46,481,708)	(45,170,051)
Total liabilities and stockholders' deficit	$ 366,988	$ 130,785

XML 13 R3.htm IDEA: XBRL DOCUMENT

Balance Sheets (Parenthetical) (Unaudited) - $ / shares	May 31, 2016	Feb. 29, 2016
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	113,951,432	113,041,432
Common stock, shares outstanding	113,951,432	113,041,432

XML 14 R4.htm IDEA: XBRL DOCUMENT

Statements of Operations (Unaudited) - USD ($)	3 Months Ended
Statements of Operations (Unaudited) - USD ($)	May 31, 2016	May 31, 2015
Income Statement [Abstract]
Net Revenues	$ 0	$ 106,327
Cost of goods sold	0	73,562
Gross Profit	0	32,765
Operating expenses:
Engineering, research and development expenses	33,788	137,487
Selling, general and administrative expenses	616,977	1,455,689
Total operating expenses	650,765	1,593,176
Loss from operations	(650,765)	(1,560,411)
Other (income) and expense:
Interest expense, net	827,947	740,700
Gain on debt settlement	(70,288)
Other income, net	(1,767)	(59,500)
Total other (income) expense	755,892	681,200
Net Loss	$ (1,406,657)	$ (2,241,611)
Total basic and diluted loss per share	$ (0.01)	$ (0.02)
Weighted average shares used to compute basic and diluted loss per share	113,848,171	113,041,432

XML 15 R5.htm IDEA: XBRL DOCUMENT

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	May 31, 2016	May 31, 2015
Cash flow from operating activities:
Net Loss	$ (1,406,657)	$ (2,241,611)
Adjustments to reconcile Net loss to net cash used in operating activities
Depreciation Expense		713
Amortization of debt discount	64,110	64,110
Gain on debt settlement	(70,288)
(Increase) decrease in:
Accounts receivable	2,115	54,352
Other current assets and deposit	96,819	39,623
Increase (decrease) in:
Accounts payable, customer deposit and accrued expenses	1,215,829	1,767,075
Net cash used in operations	(98,072)	(315,740)
Financing activities:
Proceeds from convertible notes payable
Proceeds from notes payable-net	405,000	24,000
Proceeds from notes payable-related party, net	28,208	310,000
Net cash provided by financing activities:	433,208	334,000
Net increase (decrease) in cash & cash equivalents	335,136	18,260
Cash and cash equivalents at beginning of period	22,175	34,855
Cash and cash equivalents at end of period	357,311	53,115
Cash paid during the period for:
Interest
Income taxes

XML 16 R6.htm IDEA: XBRL DOCUMENT

Accounting Policies	3 Months Ended
Accounting Policies	May 31, 2016
Accounting Policies [Abstract]
ACCOUNTING POLICIES	NOTE 1 – ACCOUNTING POLICIES Accounting principles In the opinion of management, the accompanying balance sheets and related interim statements of income and comprehensive income, and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s annual report on Form 10-K for the year ended February 29, 2016 filed on September 18, 2017 with the U.S. Securities and Exchange Commission. Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Recently Issued Accounting Pronouncements In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03, Interest–Imputation of Interest (Subtopic 835-30) (“ASU 2015-03”), which changes the presentation of debt issuance costs in financial statements. ASU 2015-03 requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. It is effective for annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The new guidance will be applied retrospectively to each prior period presented. The Company is currently in the process of evaluating the impact of adoption of ASU 2015-03 on its balance sheets. In January 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) 2016-01, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affect the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017, and upon adoption, an entity should apply the amendments by means of a cumulative-effect adjustment to the balance sheet at the beginning of the first reporting period in which the guidance is effective. Early adoption is not permitted except for the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income. The Company is currently evaluating the impact of adopting this guidance. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Topic 842 affects any entity that enters into a lease, with some specified scope exemptions. The guidance in this Update supersedes Topic 840, Leases. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For public companies, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We are currently evaluating the impact of adopting ASU No. 2016-02 on our financial statements. In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) that clarifies how to apply revenue recognition guidance related to whether an entity is a principal or an agent. ASU 2016-08 clarifies that the analysis must focus on whether the entity has control of the goods or services before they are transferred to the customer and provides additional guidance about how to apply the control principle when services are provided and when goods or services are combined with other goods or services. The effective date for ASU 2016-08 is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years. The Company has not yet determined the impact of ASU 2016-08 on its financial statements. In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation, or ASU No. 2016-09. The areas for simplification in this Update involve several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public entities, the amendments in this Update are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted in any interim or annual period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of the amendments in the same period. Amendments related to the timing of when excess tax benefits are recognized, minimum statutory withholding requirements, forfeitures, and intrinsic value should be applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of the beginning of the period in which the guidance is adopted. Amendments related to the presentation of employee taxes paid on the statement of cash flows when an employer withholds shares to meet the minimum statutory withholding requirement should be applied retrospectively. Amendments requiring recognition of excess tax benefits and tax deficiencies in the income statement and the practical expedient for estimating expected term should be applied prospectively. An entity may elect to apply the amendments related to the presentation of excess tax benefits on the statement of cash flows using either a prospective transition method or a retrospective transition method. We are currently evaluating the impact of adopting ASU No. 2016-09 on our financial statements. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which provides further guidance on identifying performance obligations and improves the operability and understandability of licensing implementation guidance. The effective date for ASU 2016-10 is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years. In May 2016, the FASB issued ASU 2016-12 “Revenue from Contracts with Customers (Topic 606) - Narrow-Scope Improvements and Practical Expedients,” which amends the guidance on transition, collectability, non-cash consideration, and the presentation of sales and other similar taxes. ASU 2016-12 clarifies that, for a contract to be considered completed at transition, all (or substantially all) of the revenue must have been recognized under legacy GAAP. In addition, ASU 2016-12 clarifies how an entity should evaluate the collectability threshold and when an entity can recognize nonrefundable consideration received as revenue if an arrangement does not meet the standard’s contract criteria. The standard allows for both retrospective and modified retrospective methods of adoption. The Company has not yet determined the impact of ASU 2016-10 on its financial statements. In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Statements," which requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2019 (fiscal year 2021 for the Company). The Company has not yet determined the potential effects of the adoption of ASU 2016-13 on its Financial Statements. In August 2016, the FASB issued ASU 2016-15, "Classification of Certain Cash Receipts and Cash Payments," which aims to eliminate diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. ASU 2016-15 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2017 (fiscal year 2019 for the Company). The Company has not yet determined the potential effects of the adoption of ASU 2016-15 on its Financial Statements. Reclassifications Certain reclassifications have been made to the comparative financial statements to conform to the current period presentation.

XML 17 R7.htm IDEA: XBRL DOCUMENT

Going Concern	3 Months Ended
Going Concern	May 31, 2016
Going Concern [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. During the Three months ended May 31, 2016 and May 31, 2015, the Company incurred losses of $1,406,657 and $2,241,611, respectively and had negative cash flows from operating activities of $98,072 and $315,740, respectively. If the Company is unable to generate profits and is unable to continue to obtain financing for its working capital requirements, it may have to curtail its business sharply or cease business altogether. Substantial additional capital resources will be required to fund continuing expenditures related to our research, development, manufacturing and business development activities. The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to retain its current financing, to obtain additional financing, and ultimately to attain profitability. The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that could result from the outcome of this uncertainty. During the next twelve months we intend to restart operations of our AuraGen/VIPER business both domestically and internationally. At the next shareholders meeting the shareholders will vote for an entire new slate of five board candidates. The new board when elected will hire a new management team. In addition we plan to acquire a new facility of approximately 45,000 square feet for operations, as well as, rebuild the engineering QA and sales teams to support the operation. We anticipate being able to fund these additions in the upcoming fiscal year.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Inventories

3 Months Ended

May 31, 2016

Inventories [Abstract]

INVENTORIES

NOTE 3 – INVENTORIES

Inventories, stated at the lower of cost (first in first out), or market consisted of the following:

	May 31, 2016			February 29, 2016
Raw materials	$	1,872,720		$	1,858,347
Finished goods		1,568,188			1,558,554
		3,440,908			3,416,901
Inventory reserve		(3,440,908	)		(3,416,901	)
	$	0		$	0

XML 19 R9.htm IDEA: XBRL DOCUMENT

Other Current Assets	3 Months Ended
Other Current Assets	May 31, 2016
Other Current Assets [Abstract]
OTHER CURRENT ASSETS	NOTE 4 – OTHER CURRENT ASSETS Other assets of $9,677 and $16,283 are comprised of vendor advances of $2,895 and $16,283 as of May 31, 2016 and February 29, 2016.

XML 20 R10.htm IDEA: XBRL DOCUMENT

Property, Plant, and Equipment

3 Months Ended

May 31, 2016

Property, Plant, and Equipment [Abstract]

PROPERTY, PLANT, AND EQUIPMENT

NOTE 5 – PROPERTY, PLANT, AND EQUIPMENT

Property, plant, and equipment consisted of the following:

	May 31, 2016			February 29, 2016
Machinery and equipment	$	964,111		$	964,111
Furniture and fixtures		163,302			163,302
		1,127,413			1,127,413
Less accumulated depreciation		(1,127,413	)		(1,127,413	)
Property, plant and equipment, net	$	0		$	0

Depreciation expense was $0 and $713 for the Three months ended May 31, 2016 and May 21, 2015, respectively.

XML 21 R11.htm IDEA: XBRL DOCUMENT

Notes Payable

3 Months Ended

May 31, 2016

Notes Payable [Abstract]

NOTES PAYABLE

NOTE 6 – NOTES PAYABLE

Notes payable consisted of the following:

	May 31, 2016		February 29, 2016

Demand notes payable, at 10% and 16%	$	4,182,468	$	3,927,468
Convertible Promissory Note dated August 10, 2012, due August 10, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 10^th of each month with the principal payment due on the maturity date. To-date, the Company has not made any interest payments as set forth in this note.		926,024		910,488
Convertible Promissory Note dated October 2, 2012, due October 2, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2^nd of each month with the principal payment due on the maturity date. To-date, the Company has not made any interest payments as set forth in this note.		463,313		456,434
Senior secured convertible notes dated May 7, 2013, due May 7, 2014, convertible into shares of our common stock at a price of $0.75 per share. The note was not repaid.		2,395,700		2,395,700
Senior secured convertible notes dated June 20, 2013, due June 20, 2014, convertible into shares of our common stock at a price of $0.50 per share. The note was not repaid.		325,000		325,000
Convertible notes dated April thru May, 2016. The notes carry an interest rate of 5% and might be converted into shares of Company’s common stock if the shareholders approve a 7:1 reverse stock split.		400,000		-

		8,292,505		8,015,090

Less: Current portion	$	6,903,168	$	6,648,168

Long-term portion	$	1,389,337	$	1,366,922

CONVERTIBLE DEBT

Future maturities of notes payable at May 31, 2016 are as follows:

Year Ending February 28,
2017	$	1,389,337
Total	$	1,389,337

7% Convertible Promissory Notes:

XML 22 R12.htm IDEA: XBRL DOCUMENT

Accrued Expenses

3 Months Ended

May 31, 2016

Accrued Expenses [Abstract]

ACCRUED EXPENSES

NOTE 7 – ACCRUED EXPENSES

Accrued expenses consisted of the following:

	May 31, 2016		February 29, 2016

Accrued payroll and related expenses	$	3,146,841	$	3,148,841
Accrued rent		214,774		218,025
Accrued interest		2,135,804		1,933,017
Other		90,000		90,000
Total	$	5,587,419	$	5,389,883

Accrued payroll and related expenses consists of salaries and vacation time accrued but not paid to employees due to our lack of financial resources.

XML 23 R13.htm IDEA: XBRL DOCUMENT

Shareholders' Equity

3 Months Ended

May 31, 2016

Shareholders' Equity [Abstract]

SHAREHOLDERS' EQUITY

NOTE 8 – SHAREHOLDERS’ EQUITY

Common Stock

During the three months ended May 31, 2016, we issued 950,000 shares of common stock were issued in settlement for a note payable balance $150,000 plus accrued interest of $15,288.

During the three months ended May 31, 2015, we did not issue any shares of common stock.

Employee Stock Options

During the Three months ended May 31, 2016, there were no stock options granted to employees.

In September, 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan. Activity in this plan is as follows:

	2006 Plan
	Weighted- Average Exercise Price		Aggregate Intrinsic Value		Number of Options
Outstanding, February 29, 2016		$0.75-$1.00	$	0.00		7,224,000
Cancelled		-		-		-
Granted		-		-		-
Outstanding, May 31, 2016		$0.75-$1.00	$	0.00		7,224,000

The exercise prices for the options outstanding at May 31, 2016, and information relating to these options is as follows:

Options Outstanding

Exercisable Options

Range of Exercise
Price

Number

Weighted
Average
Remaining
Life

Weighted
Average
Exercise
Price

Weighted
Average
Remaining
Life

Number

Weighted
Average
Exercise
Price

$0.75-$1.00

7,224,000

3.75 years

0.79

3.75 years

7,224,000

0.79

Warrants

Activity in issued and outstanding warrants is as follows:

	Number of Shares			Exercise Prices
Outstanding, February 29, 2016		36,726,208			$0.10-$1.50
Granted		-			-
Exercised		-			-
Cancelled		(1,657,188	)		$1.00-$1.50
Outstanding, May 31, 2016		35,069,020			$0.10-$1.50

There were no warrants issued in the three months ended May 31,2016.

The exercise prices for the warrants outstanding at May 31, 2016, and information relating to these warrants is as follows:

Range of Exercise Prices	Stock Warrants Outstanding		Stock Warrants Exercisable		Weighted- Average Remaining Contractual Life	Weighted- Average Exercise Price of Warrants Outstanding		Weighted- Average Exercise Price of Warrants Exercisable		Intrinsic Value
$0.10-$0.75		19,481,012		19,481,012	58 months	$	0.56	$	0.56	$	0.00
$0.75		1,082,734		1,082,734	57 months	$	0.75	$	0.75	$	0.00
$0.75		1,000,000		1,000,000	47 months	$	0.75	$	0.75	$	0.00
$0.75-$1.00		5,990,275		5,990,275	42 months	$	0.77	$	0.77	$	0.00
$1.00-$1.25		795,000		795,000	4 months	$	1.05	$	1.05	$	0.00
$1.00		6,719,999		6,719,999	3 months	$	1.00	$	1.00	$	0.00

		35,069,020		35,069,020

XML 24 R14.htm IDEA: XBRL DOCUMENT

Income Taxes	3 Months Ended
Income Taxes	May 31, 2016
Income Taxes [Abstract]
INCOME TAXES	NOTE 9 – INCOME TAXES Our effective tax rates were approximately 0.0% for the three months ended May 31, 2016 and 2015. Our effective tax rate was lower than the U.S. federal statutory rate primarily due to the fact that we record a full valuation allowance against our deferred tax assets, which is primarily comprised of net operating losses.

XML 25 R15.htm IDEA: XBRL DOCUMENT

Segment Information

3 Months Ended

May 31, 2016

Segment Information [Abstract]

SEGMENT INFORMATION

NOTE 10 – SEGMENT INFORMATION

Total net revenues from customer geographical segments are as follows for the three months ended May 31, 2016 and 2015:

	2016		2015

United States	$	0	$	30,124
Canada				-
Europe				210
Asia				20,014
Other				55,979
Total	$	0	$	106,327

XML 26 R16.htm IDEA: XBRL DOCUMENT

Significant Customers	3 Months Ended
Significant Customers	May 31, 2016
Significant Customers [Abstract]
SIGNIFICANT CUSTOMERS	NOTE 11 – SIGNIFICANT CUSTOMERS Concentration Risk In the three months ended May 31, 2016, we did not have any sales to customers. In the Three months ended May 31, 2015, we sold AuraGen related products to three significant customers whose sales comprised 45%, 32% and 17% of sales, respectively. Net accounts receivable from these customers at May 31, 2015 were $0, $0 and $0 respectively. These customers are not related to or affiliated with us.

XML 27 R17.htm IDEA: XBRL DOCUMENT

Related Parties Transactions	3 Months Ended
Related Parties Transactions	May 31, 2016
Related Parties Transactions [Abstract]
RELATED PARTIES TRANSACTIONS	NOTE 12 – RELATED PARTIES TRANSACTIONS At May 31, 2016, the balance reflected in Notes Payable and accrued interest-related party, current, includes $14,903,252 of unsecured notes payable plus accrued interest of $8,054,541 to Mr. Brelow, a member of our Board of Directors, payable on demand, bearing interest at a rate of 10% per annum. The balance of $14,880,372 plus accrued interest of $7,680,164 as of February 29, 2016. During the three months ended May 31, 2015 and May 31, 2015, interest amounting to $374,378 and $359,762 respectively, was incurred on these notes. The balance also includes $82,000 of unsecured notes payable plus accrued interest of $25,748 and $23,704 to our CEO pursuant to a demand note entered into on April 5, 2013 and an unsecured note payable to Mr. Kopple, another member of our Board of Directors in the total amount of $3,424,064 and $3,418,738 plus accrued interest of $867,234 and $784,934 with interest at a rate of 10% per annum as of May 31, 2016 and February 29, 2016, respectively. At May 31, 2016, the balance reflected in Convertible note payable and accrued interest-related party, long term, includes $1,880,851 of secured convertible notes payable net of discounts of $119,149 plus accrued interest of $796,063 to Mr. Kopple, a member of our Board of Directors.

XML 28 R18.htm IDEA: XBRL DOCUMENT

Commitments	3 Months Ended
Commitments	May 31, 2016
Commitments [Abstract]
COMMITMENTS	NOTE 13 – COMMITMENTS Our facilities consist of approximately 20,000 rented square feet in Stanton, California. The Stanton facility is currently being used for small quantity assembly and testing using components that are produced by various suppliers as well as for general offices, engineering and warehousing. The rent for the Stanton facility is $10,000 per month. The facility is not sufficient for our near term anticipated needs and the Company is actively looking for a new facility. The Company arrangements for the Stanton facility are on a month per month rent.

XML 29 R19.htm IDEA: XBRL DOCUMENT

Subsequent Events	3 Months Ended
Subsequent Events	May 31, 2016
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 14 – SUBSEQUENT EVENTS: On January 24, 2017 the Company entered into a Debt Refinancing Agreement with Mr. Breslow, a Director of the Company. Pursuant to the agreement, both Mr. Breslow and the Company acknowledged that total debt owed to Mr. Breslow was $23,872,614 including $8,890,574 of accrued interest. Mr. Breslow agreed to cancel and forgive all interest due, waive all events of default and sign a new five year convertible note in the amount of $14,930,041 providing for no interest for six months and interest of 5% per annum thereafter payable monthly in arrears. The note also provides various default provisions. The agreement further provides that $11,982,041 of the note will be converted into 7,403,705 shares of common stock concurrent with the stockholders approving a 1 for 7 reverse stock split within one year of entering this agreement and the remaining may be converted at any time thereafter post reverse split. In the absence of the approval within one year, this agreement will become null and void. The Company has elected to continue to accrue interest on this agreement until such time as the 1 for 7 reverse stock split has been approved. On January 30, 2017, the Company entered into an agreement with five of our secured creditors (the “Secured Creditors”), pursuant to which a Securities Purchase Agreement dated May 6, 2013 (the “2013 Purchase Agreement”) among the Company, the Secured Creditors, and two other parties was amended (the “Amended Agreement”). As part of the 2013 transaction, we entered into a security agreement with the Secured Creditors and two other parties (collectively the “Buyers”) pursuant to which the Buyers were granted a security interest in all of Company’s assets except for its patents and other intellectual properties. The Secured Creditors have the right to amend the 2013 Purchase Agreement on behalf of all Buyers. The Amended Agreement amends the 2013 Purchase Agreement and the original security agreement, replaces the convertible notes with “Amended Notes” and replaces the warrants with “Amended Warrants.” The Amended Notes provide that all accrued and unpaid interest on the original notes through October 31, 2016 be added to the principal amount of the Amended Notes. The Amended Notes bear interest at the rate of 0% until May 1, 2017 and 5% per annum thereafter, subject to reduction to comply with applicable law, and mature in 60 months from the effective date of a 1 for 7 reverse stock split. Upon certain financings, the Company is obligated to make a payment to the holders of the Amended Notes in the amount of 20% of the outstanding Notes. Immediately upon the effectiveness of a 1 for 7 reverse stock split, 80% of the then-unpaid principal of and all of the then accrued but unpaid interest on the Amended Notes is automatically converted. In addition, the Amended Agreement waives any and all events of default under the 2013 Purchase Agreement and related transaction documents existing on or prior to January 30, 2017 and amends the defaults and remedies section of the 2013 Purchase Agreement. Two Buyers, who together represent less than 3% of the Company’s common stock issuable upon conversion of the original notes and exercise of the original warrants, did not sign the amendment and have named the Company and the Company’s Chief Executive Officer among several defendants in a lawsuit demanding repayment of loans totaling $125,000 plus accrued interest and exemplary damages. Management believes that the two plaintiffs have no valid claim against the Company or our Chief Executive Officer. In March 2017, plaintiffs moved for partial summary adjudication against the Company and our Chief Executive Officer; however, the Court denied plaintiffs’ motion. Both the Company and Mr. Gagerman have filed demurrers seeking dismissal of this action, which remain pending at this time. On January 27, 2017, the Company entered into a joint venture (JV) agreement with a Chinese company to manufacture, market and distribute certain mobile power products based on Aura's patented technology solely for the Peoples Republic of China territories. The JV will be owned 49% by the Company and 51% by the Chinese company who will also contribute $9,750,000 to the JV. The Company is required to contribute $250,000 and a license to specific technology. In addition, the Chinese company will invest $2,000,000 in Aura at $0.20 per share for a total of 10,000,000 shares of common stock and purchase a minimum of $1,250,000 of product supported by letters of credit for distribution until the JV factory is built, equipped, and staffed. Aura has also committed to supply training and technical personnel to the JV for six months at no cost other than reimbursement for travel, room and board. The agreement was subject to the approval of the Chinese Government which was received in April, 2017. The Company is presently engaged in a dispute with one of its directors, Robert Kopple, relating to approximately $5.4 million and approximately 22 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company. In July 2017, Mr. Kopple filed suit against the Company as well as against current Directors Mr. Gagerman and Mr. Diaz-Verson together with former Directors Mr. Breslow and Mr. Howsmon in connection with these allegations. The Company believes that it has valid defenses in these matters and intends to vigorously defend against these claims.

XML 30 R20.htm IDEA: XBRL DOCUMENT

Accounting Policies (Policies)	3 Months Ended
Accounting Policies (Policies)	May 31, 2016
Accounting Policies [Abstract]
Estimates	Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03, Interest–Imputation of Interest (Subtopic 835-30) (“ASU 2015-03”), which changes the presentation of debt issuance costs in financial statements. ASU 2015-03 requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. It is effective for annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The new guidance will be applied retrospectively to each prior period presented. The Company is currently in the process of evaluating the impact of adoption of ASU 2015-03 on its balance sheets. In January 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) 2016-01, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affect the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017, and upon adoption, an entity should apply the amendments by means of a cumulative-effect adjustment to the balance sheet at the beginning of the first reporting period in which the guidance is effective. Early adoption is not permitted except for the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income. The Company is currently evaluating the impact of adopting this guidance. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Topic 842 affects any entity that enters into a lease, with some specified scope exemptions. The guidance in this Update supersedes Topic 840, Leases. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For public companies, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We are currently evaluating the impact of adopting ASU No. 2016-02 on our financial statements. In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) that clarifies how to apply revenue recognition guidance related to whether an entity is a principal or an agent. ASU 2016-08 clarifies that the analysis must focus on whether the entity has control of the goods or services before they are transferred to the customer and provides additional guidance about how to apply the control principle when services are provided and when goods or services are combined with other goods or services. The effective date for ASU 2016-08 is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years. The Company has not yet determined the impact of ASU 2016-08 on its financial statements. In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation, or ASU No. 2016-09. The areas for simplification in this Update involve several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public entities, the amendments in this Update are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted in any interim or annual period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of the amendments in the same period. Amendments related to the timing of when excess tax benefits are recognized, minimum statutory withholding requirements, forfeitures, and intrinsic value should be applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of the beginning of the period in which the guidance is adopted. Amendments related to the presentation of employee taxes paid on the statement of cash flows when an employer withholds shares to meet the minimum statutory withholding requirement should be applied retrospectively. Amendments requiring recognition of excess tax benefits and tax deficiencies in the income statement and the practical expedient for estimating expected term should be applied prospectively. An entity may elect to apply the amendments related to the presentation of excess tax benefits on the statement of cash flows using either a prospective transition method or a retrospective transition method. We are currently evaluating the impact of adopting ASU No. 2016-09 on our financial statements. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which provides further guidance on identifying performance obligations and improves the operability and understandability of licensing implementation guidance. The effective date for ASU 2016-10 is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years. In May 2016, the FASB issued ASU 2016-12 “Revenue from Contracts with Customers (Topic 606) - Narrow-Scope Improvements and Practical Expedients,” which amends the guidance on transition, collectability, non-cash consideration, and the presentation of sales and other similar taxes. ASU 2016-12 clarifies that, for a contract to be considered completed at transition, all (or substantially all) of the revenue must have been recognized under legacy GAAP. In addition, ASU 2016-12 clarifies how an entity should evaluate the collectability threshold and when an entity can recognize nonrefundable consideration received as revenue if an arrangement does not meet the standard’s contract criteria. The standard allows for both retrospective and modified retrospective methods of adoption. The Company has not yet determined the impact of ASU 2016-10 on its financial statements. In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Statements," which requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2019 (fiscal year 2021 for the Company). The Company has not yet determined the potential effects of the adoption of ASU 2016-13 on its Financial Statements. In August 2016, the FASB issued ASU 2016-15, "Classification of Certain Cash Receipts and Cash Payments," which aims to eliminate diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. ASU 2016-15 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2017 (fiscal year 2019 for the Company). The Company has not yet determined the potential effects of the adoption of ASU 2016-15 on its Financial Statements.
Reclassifications	Reclassifications Certain reclassifications have been made to the comparative financial statements to conform to the current period presentation.

XML 31 R21.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

3 Months Ended

May 31, 2016

Inventories [Abstract]

Schedule of inventories, stated at the lower of cost

	May 31, 2016			February 29, 2016

Raw materials	$	1,872,720		$	1,858,347
Finished goods		1,568,188			1,558,554

		3,440,908			3,416,901
Inventory reserve		(3,440,908	)		(3,416,901	)

	$	0		$	0

XML 32 R22.htm IDEA: XBRL DOCUMENT

Property, Plant, and Equipment (Tables)

3 Months Ended

May 31, 2016

Property, Plant, and Equipment [Abstract]

Schedule of property, plant, and equipment

	May 31, 2016			February 29, 2016
Machinery and equipment	$	964,111		$	964,111
Furniture and fixtures		163,302			163,302
		1,127,413			1,127,413
Less accumulated depreciation		(1,127,413	)		(1,127,413	)
Property, plant and equipment, net	$	0		$	0

XML 33 R23.htm IDEA: XBRL DOCUMENT

Notes Payable (Tables)

3 Months Ended

May 31, 2016

Notes Payable [Abstract]

Schedule of notes payable

	May 31, 2016		February 29, 2016

Demand notes payable, at 10% and 16%	$	4,182,468	$	3,927,468
Convertible Promissory Note dated August 10, 2012, due August 10, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 10^th of each month with the principal payment due on the maturity date. To-date, the Company has not made any interest payments as set forth in this note.		926,024		910,488
Convertible Promissory Note dated October 2, 2012, due October 2, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2^nd of each month with the principal payment due on the maturity date. To-date, the Company has not made any interest payments as set forth in this note.		463,313		456,434
Senior secured convertible notes dated May 7, 2013, due May 7, 2014, convertible into shares of our common stock at a price of $0.75 per share. The note was not repaid.		2,395,700		2,395,700
Senior secured convertible notes dated June 20, 2013, due June 20, 2014, convertible into shares of our common stock at a price of $0.50 per share. The note was not repaid.		325,000		325,000
Convertible notes dated April thru May, 2016. The notes carry an interest rate of 5% and might be converted into shares of Company’s common stock if the shareholders approve a 7:1 reverse stock split.		400,000		-

		8,292,505		8,015,090

Less: Current portion	$	6,903,168	$	6,648,168

Long-term portion	$	1,389,337	$	1,366,922

Schedule of future maturities of notes payable

Year Ending February 28,
2017	$	1,389,337
Total	$	1,389,337

XML 34 R24.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Tables)

3 Months Ended

May 31, 2016

Accrued Expenses [Abstract]

Schedule of accrued expenses

	May 31, 2016		February 29, 2016

Accrued payroll and related expenses	$	3,146,841	$	3,148,841
Accrued rent		214,774		218,025
Accrued interest		2,135,804		1,933,017
Other		90,000		90,000
Total	$	5,587,419	$	5,389,883

XML 35 R25.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Tables)

3 Months Ended

May 31, 2016

Shareholders' Equity [Abstract]

Schedule of 2006 employee stock option plan

	2006 Plan
	Weighted- Average Exercise Price		Aggregate Intrinsic Value		Number of Options
Outstanding, February 29, 2016		$0.75-$1.00	$	0.00		7,224,000
Cancelled		-		-		-
Granted		-		-		-
Outstanding, May 31, 2016		$0.75-$1.00	$	0.00		7,224,000

Schedule of exercise price options outstanding

Options Outstanding

Exercisable Options

Range of Exercise

Price

Number

Weighted Average Remaining Life

Weighted Average Exercise Price

Weighted Average Remaining Life

Number

Weighted Average Exercise Price

$0.75-$1.00

7,224,000

3.75 years

0.79

3.75 years

7,224,000

0.79

Schedule of activity in issued and outstanding warrants

	Number of Shares			Exercise Prices
Outstanding, February 29, 2016		36,726,208			$0.10-$1.50
Granted		-			-
Exercised		-			-
Cancelled		(1,657,188	)		$1.00-$1.50
Outstanding, May 31, 2016		35,069,020			$0.10-$1.50

Schedule of exercise prices warrants outstanding

Range of Exercise Prices	Stock Warrants Outstanding		Stock Warrants Exercisable		Weighted-Average Remaining Contractual Life	Weighted-Average Exercise Price of Warrants Outstanding		Weighted-Average Exercise Price of Warrants Exercisable		Intrinsic Value
$0.10-$0.75		19,481,012		19,481,012	58 months	$	0.56	$	0.56	$	0.00
$0.75		1,082,734		1,082,734	57 months	$	0.75	$	0.75	$	0.00
$0.75		1,000,000		1,000,000	47 months	$	0.75	$	0.75	$	0.00
$0.75-$1.00		5,990,275		5,990,275	42 months	$	0.77	$	0.77	$	0.00
$1.00-$1.25		795,000		795,000	4 months	$	1.05	$	1.05	$	0.00
$1.00		6,719,999		6,719,999	3 months	$	1.00	$	1.00	$	0.00

		35,069,020		35,069,020

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

XML 36 R26.htm IDEA: XBRL DOCUMENT

Segment Information (Tables)

3 Months Ended

May 31, 2016

Segment Information [Abstract]

Summary of revenues from customer geographical segments

	2016		2015

United States	$	0	$	30,124
Canada				-
Europe				210
Asia				20,014
Other				55,979
Total	$	0	$	106,327

XML 37 R27.htm IDEA: XBRL DOCUMENT

Going Concern (Details)	3 Months Ended
Going Concern (Details)	May 31, 2016 USD ($) ft²	May 31, 2015 USD ($)
Going Concern (Textual)
Incurred losses	$ (1,406,657)	$ (2,241,611)
Cash flows from operating activities	$ (98,072)	$ (315,740)
Area of land \| ft²	45,000

XML 38 R28.htm IDEA: XBRL DOCUMENT

Inventories (Details) - USD ($)	May 31, 2016	Feb. 29, 2016
Inventories [Abstract]
Raw materials	$ 1,872,720	$ 1,858,347
Finished goods	1,568,188	1,558,554
Inventory gross	3,440,908	3,416,901
Inventory reserve	(3,440,908)	(3,416,901)
Inventory net	$ 0	$ 0

XML 39 R29.htm IDEA: XBRL DOCUMENT

Other Current Assets (Details) - USD ($)	May 31, 2016	Feb. 29, 2016
Other Current Assets (Textual)
Other assets	$ 9,677	$ 16,282
Vendor advances	$ 2,895	$ 16,283

XML 40 R30.htm IDEA: XBRL DOCUMENT

Property, Plant, and Equipment (Details) - USD ($)	May 31, 2016	Feb. 29, 2016
Property, Plant, and Equipment [Abstract]
Machinery and equipment	$ 964,111	$ 964,111
Furniture and fixtures	163,302	163,302
Property, plant and equipment, gross	1,127,413	1,127,413
Less accumulated depreciation	(1,127,413)	(1,127,413)
Property, plant, and equipment, net	$ 0	$ 0

XML 41 R31.htm IDEA: XBRL DOCUMENT

Property, Plant, and Equipment (Details Textual) - USD ($)	3 Months Ended
	May 31, 2016	May 31, 2015
Property, Plant, and Equipment (Textual)
Depreciation expense		$ 713

XML 42 R32.htm IDEA: XBRL DOCUMENT

Notes Payable (Details) - USD ($)	May 31, 2016	Feb. 29, 2016
Debt Instrument [Line Items]
Convertible notes payable	$ 8,292,505	$ 8,015,090
Less: Current portion	6,903,168	6,648,168
Long-term portion	1,389,337	1,366,922
Demand notes payable [Member]
Debt Instrument [Line Items]
Demand notes payable	4,182,468	3,927,468
Convertible Promissory Note dated August 10, 2012 [Member]
Debt Instrument [Line Items]
Convertible notes payable	926,024	910,488
Convertible Promissory Note dated October 2, 2012 [Member]
Debt Instrument [Line Items]
Convertible notes payable	463,313	456,434
Senior secured convertible notes dated May 7, 2013 [Member]
Debt Instrument [Line Items]
Convertible notes payable	2,395,700	2,395,700
Senior secured convertible notes dated June 20, 2013 [Member]
Debt Instrument [Line Items]
Convertible notes payable	325,000	325,000
Convertible notes dated April thru May, 2016 [Member]
Debt Instrument [Line Items]
Convertible notes payable	$ 400,000

XML 43 R33.htm IDEA: XBRL DOCUMENT

Notes Payable (Parenthetical) (Details)	3 Months Ended
Notes Payable (Parenthetical) (Details)	May 31, 2016 $ / shares
Demand notes payable [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Notes payable interest rate	10.00%
Demand notes payable [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Notes payable interest rate	16.00%
Convertible Promissory Note dated August 10, 2012 [Member]
Debt Instrument [Line Items]
Notes payable interest rate	7.00%
Due date of notes	Aug. 10, 2017
Conversion price per share of notes payable	$ 0.76
Convertible Promissory Note dated October 2, 2012 [Member]
Debt Instrument [Line Items]
Notes payable interest rate	7.00%
Due date of notes	Oct. 02, 2017
Conversion price per share of notes payable	$ 0.76
Senior secured convertible notes dated May 7, 2013 [Member]
Debt Instrument [Line Items]
Due date of notes	May 07, 2014
Conversion price per share of notes payable	$ 0.75
Senior secured convertible notes dated June 20, 2013 [Member]
Debt Instrument [Line Items]
Due date of notes	Jun. 20, 2014
Conversion price per share of notes payable	$ 0.50
Convertible notes dated April thru May, 2016 [Member]
Debt Instrument [Line Items]
Notes payable interest rate	5.00%
Reverse stock split	7:1 reverse stock split.

XML 44 R34.htm IDEA: XBRL DOCUMENT

Notes Payable (Details 1)	May 31, 2016 USD ($)
Year Ending February 28
2017	$ 1,389,337
Total	$ 1,389,337

XML 45 R35.htm IDEA: XBRL DOCUMENT

Notes Payable (Details Textual)						3 Months Ended
Notes Payable (Details Textual)	Aug. 19, 2013 USD ($) $ / shares shares	Jun. 20, 2013 USD ($) $ / shares shares	May 07, 2013 USD ($) Notes $ / shares shares	Oct. 02, 2012 USD ($)	Aug. 10, 2012 USD ($)	May 31, 2016 USD ($)	May 31, 2015 USD ($)
Notes Payable (Textual)
Amortization of debt discount						$ 64,110	$ 64,110
Convertible Secured Notes [Member] \| Warrant [Member]
Notes Payable (Textual)
Pre conversion debt principal amount			$ 750,000
Conversion price per share of notes payable \| $ / shares			$ 0.75
Term of warrant			7 years
Amortization of debt discount			$ 235,985
Exercise price per common share under warrant one (in dollars per share) \| $ / shares			$ 0.75
Number of common shares entitlement on exercise of warrant one (in shares) \| shares			1,000,000
Notes maturity date, term			1 year
Notes payable interest rate			16.00%
Kenmont Capital Partners [Member] \| Convertible Secured Notes [Member]
Notes Payable (Textual)
Pre conversion debt principal amount			$ 1,000,000
Principal value of convertible notes			$ 1,087,000
Conversion price per share of notes payable \| $ / shares			$ 0.75
Term of warrant			7 years
Amortization of debt discount			$ 342,020
Exercise price per common share under warrant one (in dollars per share) \| $ / shares			$ 0.75
Number of common shares entitlement on exercise of warrant one (in shares) \| shares			1,449,333
Number of notes payable to transferred \| Notes			4
Notes maturity date, term			1 year
LPD Investments [Member] \| Convertible Secured Notes [Member]
Notes Payable (Textual)
Pre conversion debt principal amount			$ 550,000
Principal value of convertible notes			$ 558,700
Conversion price per share of notes payable \| $ / shares			$ 0.75
Term of warrant			7 years
Amortization of debt discount			$ 175,793
Exercise price per common share under warrant one (in dollars per share) \| $ / shares			$ 0.75
Number of common shares entitlement on exercise of warrant one (in shares) \| shares			744,933
Number of notes payable to transferred \| Notes			2
Notes maturity date, term			1 year
Holder [Member] \| Convertible Secured Notes [Member]
Notes Payable (Textual)
Pre conversion debt principal amount		$ 325,000
Conversion price per share of notes payable \| $ / shares		$ 0.50
Term of warrant		7 years
Amortization of debt discount		$ 63,622
Exercise price per common share under warrant one (in dollars per share) \| $ / shares		$ 0.75	$ 0.75
Number of common shares entitlement on exercise of warrant one (in shares) \| shares		433,334
Notes maturity date, term		1 year
Holder [Member] \| Board of Directors [Member] \| Convertible Secured Notes [Member]
Notes Payable (Textual)
Pre conversion debt principal amount	$ 2,500,000
Conversion price per share of notes payable \| $ / shares	$ 0.50
Term of warrant	7 years
Amortization of debt discount	$ 667,118
Exercise price per common share under warrant one (in dollars per share) \| $ / shares	$ 0.75
Number of common shares entitlement on exercise of warrant one (in shares) \| shares	5,000,000
Notes maturity date, term	4 years
Notes payable interest rate	9.50%
Conversion to demand note payable		$ 500,000
Unsecured Convertible Promissory Note [Member]
Notes Payable (Textual)
Pre conversion debt principal amount				$ 500,000	$ 1,000,000
Amortization of debt discount				$ 137,583	$ 310,723
Due date of notes				Oct. 02, 2012	Aug. 10, 2017
Notes maturity date, term				5 years	5 years
Notes payable interest rate				7.00%	7.00%
Description of convertible promissory note				The note holder will receive interest on the unpaid principal amount payable monthly in arrears on the second day of each calendar month commencing November 2, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year.	The note holder will receive interest on the unpaid principal amount payable monthly in arrears on the tenth day of each calendar month commencing September 10, 2012. Interest shall be computed on the actual number of days elapsed over a 360-day year.

XML 46 R36.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Details) - USD ($)	May 31, 2016	Feb. 29, 2016
Accrued Expenses [Abstract]
Accrued payroll and related expenses	$ 3,146,841	$ 3,148,841
Accrued rent	214,774	218,025
Accrued interest	2,135,804	1,933,017
Other	90,000	90,000
Total	$ 5,587,418	$ 5,389,883

XML 47 R37.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - 2006 Plan [Member]	3 Months Ended
Shareholders' Equity (Details) - 2006 Plan [Member]	May 31, 2016 USD ($) $ / shares shares
Weighted-Average Exercise Price
Weighted-Average Exercise Price, Cancelled
Weighted-Average Exercise Price, Granted
Aggregate Intrinsic Value
Aggregate Intrinsic Value, Outstanding \| $	$ 0
Aggregate Intrinsic Value, Outstanding \| $	$ 0
Number of Options
Number of Options, Outstanding \| shares	7,224,000
Number of Options, Cancelled \| shares
Number of Options, Granted \| shares
Number of Options, Outstanding \| shares	7,224,000
Minimum [Member]
Weighted-Average Exercise Price
Weighted-Average Exercise Price, Outstanding	$ 0.75
Weighted-Average Exercise Price, Outstanding	0.75
Maximum [Member]
Weighted-Average Exercise Price
Weighted-Average Exercise Price, Outstanding	1.00
Weighted-Average Exercise Price, Outstanding	$ 1.00

XML 48 R38.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details 1)	3 Months Ended
Shareholders' Equity (Details 1)	May 31, 2016 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Range of Exercise Price, Minimum	$ 0.75
Options Outstanding, Range of Exercise Price, Maximum	$ 1.00
Options Outstanding, Number \| shares	7,224,000
Options Outstanding, Weighted Average Remaining Life	3 years 9 months
Options Outstanding, Weighted Average Exercise Price	$ 0.79
Exercisable Options, Weighted Average Remaining Life	3 years 9 months
Exercisable Options, Number \| shares	7,224,000
Exercisable Options, Weighted Average Exercise Price	$ 0.79

XML 49 R39.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details 2)	3 Months Ended
Shareholders' Equity (Details 2)	May 31, 2016 $ / shares shares
Class of Stock [Line Items]
Number of Shares, Outstanding \| shares	35,069,020
Warrants [Member]
Class of Stock [Line Items]
Number of Shares, Outstanding \| shares	36,726,208
Number of Shares, Granted \| shares
Number of Shares, Exercised \| shares
Number of Shares, Cancelled \| shares	(1,657,188)
Number of Shares, Outstanding \| shares	35,069,020
Exercise Prices, Granted
Exercise Prices, Exercised
Warrants [Member] \| Maximum [Member]
Class of Stock [Line Items]
Exercise Prices, Outstanding	1.50
Exercise Prices, Cancelled	1.50
Exercise Prices, Outstanding	1.50
Warrants [Member] \| Minimum [Member]
Class of Stock [Line Items]
Exercise Prices, Outstanding	0.10
Exercise Prices, Cancelled	1.00
Exercise Prices, Outstanding	$ 0.10

XML 50 R40.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details 3)	3 Months Ended
Shareholders' Equity (Details 3)	May 31, 2016 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Warrants Outstanding \| shares	35,069,020
Stock Warrants Exercisable \| shares	35,069,020
$0.10-$0.75 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Warrants Outstanding \| shares	19,481,012
Stock Warrants Exercisable \| shares	19,481,012
Weighted-Average Remaining Contractual Life	58 months
Weighted-Average Exercise Price of Warrants Outstanding	$ 0.56
Weighted-Average Exercise Price of Warrants Exercisable	0.56
Intrinsic Value	0.00
$0.10-$0.75 [Member] \| Maximum [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices	0.75
$0.10-$0.75 [Member] \| Minimum [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices	0.10
$0.75 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices	$ 0.75
Stock Warrants Outstanding \| shares	1,082,734
Stock Warrants Exercisable \| shares	1,082,734
Weighted-Average Remaining Contractual Life	57 months
Weighted-Average Exercise Price of Warrants Outstanding	$ 0.75
Weighted-Average Exercise Price of Warrants Exercisable	0.75
Intrinsic Value	0.00
$0.75 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices	$ 0.75
Stock Warrants Outstanding \| shares	1,000,000
Stock Warrants Exercisable \| shares	1,000,000
Weighted-Average Remaining Contractual Life	47 months
Weighted-Average Exercise Price of Warrants Outstanding	$ 0.75
Weighted-Average Exercise Price of Warrants Exercisable	0.75
Intrinsic Value	$ 0.00
$0.75-$1.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Warrants Outstanding \| shares	5,990,275
Stock Warrants Exercisable \| shares	5,990,275
Weighted-Average Remaining Contractual Life	42 months
Weighted-Average Exercise Price of Warrants Outstanding	$ 0.77
Weighted-Average Exercise Price of Warrants Exercisable	0.77
Intrinsic Value	0.00
$0.75-$1.00 [Member] \| Maximum [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices	1.00
$0.75-$1.00 [Member] \| Minimum [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices	$ 0.75
$1.00-$1.25 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Warrants Outstanding \| shares	795,000
Stock Warrants Exercisable \| shares	795,000
Weighted-Average Remaining Contractual Life	4 months
Weighted-Average Exercise Price of Warrants Outstanding	$ 1.05
Weighted-Average Exercise Price of Warrants Exercisable	1.05
Intrinsic Value	0.00
$1.00-$1.25 [Member] \| Maximum [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices	1.25
$1.00-$1.25 [Member] \| Minimum [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices	1.00
$1.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices	$ 1.00
Stock Warrants Outstanding \| shares	6,719,999
Stock Warrants Exercisable \| shares	6,719,999
Weighted-Average Remaining Contractual Life	3 months
Weighted-Average Exercise Price of Warrants Outstanding	$ 1.00
Weighted-Average Exercise Price of Warrants Exercisable	1.00
Intrinsic Value	$ 0.00

XML 51 R41.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details Textual)	3 Months Ended
Shareholders' Equity (Details Textual)	May 31, 2016 USD ($) shares
Shareholders' Equity (Textual)
Common stock shares issued \| shares	950,000
Note payable balance	$ 150,000
Accrued interest	$ 15,288

XML 52 R42.htm IDEA: XBRL DOCUMENT

Income Taxes (Details)	3 Months Ended
Income Taxes (Details)	May 31, 2016	May 31, 2015
Income Taxes (Textual)
Effective tax rates	0.00%	0.00%

XML 53 R43.htm IDEA: XBRL DOCUMENT

Segment Information (Details) - USD ($)	3 Months Ended
Segment Information (Details) - USD ($)	May 31, 2016	May 31, 2015
Segment Reporting , Revenue Reconciling Item [Line Items]
Revenues, Total	$ 0	$ 106,327
United States [Member]
Segment Reporting , Revenue Reconciling Item [Line Items]
Revenues, Total	0	30,124
Canada [Member]
Segment Reporting , Revenue Reconciling Item [Line Items]
Revenues, Total
Europe [Member]
Segment Reporting , Revenue Reconciling Item [Line Items]
Revenues, Total		210
Asia [Member]
Segment Reporting , Revenue Reconciling Item [Line Items]
Revenues, Total		20,014
Other [Member]
Segment Reporting , Revenue Reconciling Item [Line Items]
Revenues, Total		$ 55,979

XML 54 R44.htm IDEA: XBRL DOCUMENT

Segment Information (Details Textual)	3 Months Ended
Segment Information (Details Textual)	May 31, 2016 Segments
Segment Information (Textual)
Number of operating segment	1

XML 55 R45.htm IDEA: XBRL DOCUMENT

Significant Customers (Details)	3 Months Ended
Significant Customers (Details)	May 31, 2015 USD ($) Individual
Significant Customer 1 [Member]
Significant Customers (Textual)
Percentage sales significant customers	45.00%
Net accounts receivable from significant customers	$ 0
Significant Customer 2 [Member]
Significant Customers (Textual)
Percentage sales significant customers	32.00%
Net accounts receivable from significant customers	$ 0
Significant Customer 3 [Member]
Significant Customers (Textual)
Percentage sales significant customers	17.00%
Net accounts receivable from significant customers	$ 0
Customer Concentration Risk [Member]
Significant Customers (Textual)
Number of significant customers \| Individual	3

XML 56 R46.htm IDEA: XBRL DOCUMENT

Related Parties Transactions (Details) - USD ($)	3 Months Ended		12 Months Ended
Related Parties Transactions (Details) - USD ($)	May 31, 2016	May 31, 2015	Feb. 29, 2016
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	$ 27,356,841		$ 26,869,911
Interest expense incurred on unsecured notes payable		$ 374,378
Convertible note payable and accrued interest-related party, net of discount	$ 2,676,913		2,560,425
Mr. Breslow [Member]
Related Party Transaction [Line Items]
Related party transaction, rate (in hundredths)	10.00%
Interest expense incurred on unsecured notes payable		$ 359,762
Mr. Breslow [Member] \| Unsecured note payable [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	$ 14,903,252		14,880,372
Mr. Breslow [Member] \| Accrued interest [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	$ 8,054,541		$ 7,680,164
CEO [Member]
Related Party Transaction [Line Items]
Related party transaction, date	Apr. 05, 2013
CEO [Member] \| Unsecured note payable [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	$ 82,000
CEO [Member] \| Accrued interest [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	$ 25,748
Mr. Kopple [Member]
Related Party Transaction [Line Items]
Related party transaction, rate (in hundredths)	10.00%		10.00%
Mr. Kopple [Member] \| Convertible Secured Notes [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	$ 23,704
Convertible note payable and accrued interest-related party, net of discount	1,880,851
Discount on notes payable	119,149
Mr. Kopple [Member] \| Unsecured note payable [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	3,424,064		$ 3,418,738
Mr. Kopple [Member] \| Accrued interest [Member]
Related Party Transaction [Line Items]
Unsecured notes payable and accrued interest- related party	867,234		$ 784,934
Convertible note payable and accrued interest-related party, net of discount	$ 796,063

XML 57 R47.htm IDEA: XBRL DOCUMENT

Commitments (Details)	3 Months Ended
Commitments (Details)	May 31, 2016 USD ($) ft²
Commitments (Textual)
Area of facility (in square feet) \| ft²	20,000
Rent per month \| $	$ 10,000

XML 58 R48.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details) - USD ($)	1 Months Ended			3 Months Ended
Subsequent Events (Details) - USD ($)	Jan. 30, 2017	Jan. 27, 2017	Jan. 24, 2017	May 31, 2016	May 31, 2015	Feb. 29, 2016
Subsequent Events (Textual)
Accrued interest				$ 15,288
Convertible note				8,292,505		$ 8,015,090
Interest				$ 827,947	$ 740,700
Stock warrants outstanding				35,069,020
Board of Directors [Member] \| July 2017 [Member]
Subsequent Events (Textual)
Warrants issued value				$ 5,400,000
Stock warrants outstanding				22,000,000
Subsequent Events [Member]
Subsequent Events (Textual)
Convertible note	$ 4,095,700
Convertible notes, description	The Amended Notes bear interest at the rate of 0% until May 1, 2017 and 5% per annum thereafter, subject to reduction to comply with applicable law, and mature in 60 months from the effective date of a 1 for 7 reverse stock split. Upon certain financings, the Company is obligated to make a payment to the holders of the Amended Notes in the amount of 20% of the outstanding Notes. Immediately upon the effectiveness of a 1 for 7 reverse stock split, 80% of the then-unpaid principal of and all of the then accrued but unpaid interest on the Amended Notes is automatically converted.
Interest	$ 1,606,884
Repayment of loans	$ 125,000
Subsequent Events [Member] \| Debt Refinancing Agreement [Member]
Subsequent Events (Textual)
Total debt			$ 23,872,614
Accrued interest			8,890,574
Convertible note			$ 14,930,041
New debt agreement, term			5 years
Interest rate			5.00%
Convertible note, amount			$ 11,982,041
Convertible note, shares			7,403,705
Reverse stock split, description			The stockholders approving a 1 for 7 reverse stock split within one year of entering this agreement and the remaining may be converted at any time thereafter post reverse split. In the absence of the approval within one year, this agreement will become null and void. The Company has elected to continue to accrue interest on this agreement until such time as the 1 for 7 reverse stock split has been approved.
Subsequent Events [Member] \| Joint venture (JV) agreement [Member]
Subsequent Events (Textual)
Payments for joint venture agreement		$ 250,000
Joint venture cost method interest rate, percentage		49.00%
Subsequent Events [Member] \| Chinese company [Member]
Subsequent Events (Textual)
Payments for joint venture agreement		$ 9,750,000
Ownership percentage in joint venture		51.00%
Sale of equity method investments interest		$ 2,000,000
Shares issue of price per share		$ 0.20
Sale of common stock issued		10,000,000
Common stock purchase minimum amount		$ 1,250,000

EXCEL 59 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * / var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 61 report.css IDEA: XBRL DOCUMENT / Updated 2009-11-04 / / v2.2.0.24 / / DefRef Styles / ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } / Report Styles / ..pl a, .pl a:visited { color: black; text-decoration: none; } / table / ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } / Top labels / ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; / word-wrap: break-word; / } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } / Header rows... / ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } / Calendars... / ..report .rc { background-color: #f0f0f0; } / Even rows... / ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } / Odd rows... / ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } / styles for footnote marker / ..report .fn { white-space: nowrap; } / styles for numeric types / ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } / styles for text types / ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 63 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 118 184 1 false 41 0 false 8 false false R1.htm 001 - Document - Document and Entity Information Sheet http://aurasystems.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Balance Sheets (Unaudited) Sheet http://aurasystems.com/role/BalanceSheetsUnaudited Balance Sheets (Unaudited) Statements 2 false false R3.htm 003 - Statement - Balance Sheets (Parenthetical) (Unaudited) Sheet http://aurasystems.com/role/BalanceSheetsParentheticalUnaudited Balance Sheets (Parenthetical) (Unaudited) Statements 3 false false R4.htm 004 - Statement - Statements of Operations (Unaudited) Sheet http://aurasystems.com/role/StatementsOfOperationsUnaudited Statements of Operations (Unaudited) Statements 4 false false R5.htm 005 - Statement - Statements of Cash Flows (Unaudited) Sheet http://aurasystems.com/role/StatementsOfCashFlowsUnaudited Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 006 - Disclosure - Accounting Policies Sheet http://aurasystems.com/role/AccountingPolicies Accounting Policies Notes 6 false false R7.htm 007 - Disclosure - Going Concern Sheet http://aurasystems.com/role/GoingConcern Going Concern Notes 7 false false R8.htm 008 - Disclosure - Inventories Sheet http://aurasystems.com/role/Inventories Inventories Notes 8 false false R9.htm 009 - Disclosure - Other Current Assets Sheet http://aurasystems.com/role/OtherCurrentAssets Other Current Assets Notes 9 false false R10.htm 010 - Disclosure - Property, Plant, and Equipment Sheet http://aurasystems.com/role/PropertyPlantAndEquipment Property, Plant, and Equipment Notes 10 false false R11.htm 011 - Disclosure - Notes Payable Notes http://aurasystems.com/role/NotesPayable Notes Payable Notes 11 false false R12.htm 012 - Disclosure - Accrued Expenses Sheet http://aurasystems.com/role/AccruedExpenses Accrued Expenses Notes 12 false false R13.htm 013 - Disclosure - Shareholders' Equity Sheet http://aurasystems.com/role/ShareholdersEquity Shareholders' Equity Notes 13 false false R14.htm 014 - Disclosure - Income Taxes Sheet http://aurasystems.com/role/IncomeTaxes Income Taxes Notes 14 false false R15.htm 015 - Disclosure - Segment Information Sheet http://aurasystems.com/role/SegmentInformation Segment Information Notes 15 false false R16.htm 016 - Disclosure - Significant Customers Sheet http://aurasystems.com/role/SignificantCustomers Significant Customers Notes 16 false false R17.htm 017 - Disclosure - Related Parties Transactions Sheet http://aurasystems.com/role/RelatedPartiesTransactions Related Parties Transactions Notes 17 false false R18.htm 018 - Disclosure - Commitments Sheet http://aurasystems.com/role/Commitments Commitments Notes 18 false false R19.htm 019 - Disclosure - Subsequent Events Sheet http://aurasystems.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 020 - Disclosure - Accounting Policies (Policies) Sheet http://aurasystems.com/role/AccountingPoliciesPolicies Accounting Policies (Policies) Policies http://aurasystems.com/role/AccountingPolicies 20 false false R21.htm 021 - Disclosure - Inventories (Tables) Sheet http://aurasystems.com/role/InventoriesTables Inventories (Tables) Tables http://aurasystems.com/role/Inventories 21 false false R22.htm 022 - Disclosure - Property, Plant, and Equipment (Tables) Sheet http://aurasystems.com/role/PropertyPlantAndEquipmentTables Property, Plant, and Equipment (Tables) Tables http://aurasystems.com/role/PropertyPlantAndEquipment 22 false false R23.htm 023 - Disclosure - Notes Payable (Tables) Notes http://aurasystems.com/role/NotesPayableTables Notes Payable (Tables) Tables http://aurasystems.com/role/NotesPayable 23 false false R24.htm 024 - Disclosure - Accrued Expenses (Tables) Sheet http://aurasystems.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://aurasystems.com/role/AccruedExpenses 24 false false R25.htm 025 - Disclosure - Shareholders' Equity (Tables) Sheet http://aurasystems.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://aurasystems.com/role/ShareholdersEquity 25 false false R26.htm 026 - Disclosure - Segment Information (Tables) Sheet http://aurasystems.com/role/SegmentInformationTables Segment Information (Tables) Tables http://aurasystems.com/role/SegmentInformation 26 false false R27.htm 027 - Disclosure - Going Concern (Details) Sheet http://aurasystems.com/role/GoingConcernDetails Going Concern (Details) Details http://aurasystems.com/role/GoingConcern 27 false false R28.htm 028 - Disclosure - Inventories (Details) Sheet http://aurasystems.com/role/InventoriesDetails Inventories (Details) Details http://aurasystems.com/role/InventoriesTables 28 false false R29.htm 029 - Disclosure - Other Current Assets (Details) Sheet http://aurasystems.com/role/OtherCurrentAssetsDetails Other Current Assets (Details) Details http://aurasystems.com/role/OtherCurrentAssets 29 false false R30.htm 030 - Disclosure - Property, Plant, and Equipment (Details) Sheet http://aurasystems.com/role/PropertyPlantAndEquipmentDetails Property, Plant, and Equipment (Details) Details http://aurasystems.com/role/PropertyPlantAndEquipmentTables 30 false false R31.htm 031 - Disclosure - Property, Plant, and Equipment (Details Textual) Sheet http://aurasystems.com/role/PropertyPlantAndEquipmentDetailsTextual Property, Plant, and Equipment (Details Textual) Details http://aurasystems.com/role/PropertyPlantAndEquipmentTables 31 false false R32.htm 032 - Disclosure - Notes Payable (Details) Notes http://aurasystems.com/role/NotesPayableDetails Notes Payable (Details) Details http://aurasystems.com/role/NotesPayableTables 32 false false R33.htm 033 - Disclosure - Notes Payable (Parenthetical) (Details) Notes http://aurasystems.com/role/NotesPayableParentheticalDetails Notes Payable (Parenthetical) (Details) Details http://aurasystems.com/role/NotesPayableTables 33 false false R34.htm 034 - Disclosure - Notes Payable (Details 1) Notes http://aurasystems.com/role/NotesPayableDetails1 Notes Payable (Details 1) Details http://aurasystems.com/role/NotesPayableTables 34 false false R35.htm 035 - Disclosure - Notes Payable (Details Textual) Notes http://aurasystems.com/role/NotesPayableDetailsTextual Notes Payable (Details Textual) Details http://aurasystems.com/role/NotesPayableTables 35 false false R36.htm 036 - Disclosure - Accrued Expenses (Details) Sheet http://aurasystems.com/role/AccruedExpensesDetails Accrued Expenses (Details) Details http://aurasystems.com/role/AccruedExpensesTables 36 false false R37.htm 037 - Disclosure - Shareholders' Equity (Details) Sheet http://aurasystems.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://aurasystems.com/role/ShareholdersEquityTables 37 false false R38.htm 038 - Disclosure - Shareholders' Equity (Details 1) Sheet http://aurasystems.com/role/ShareholdersEquityDetails1 Shareholders' Equity (Details 1) Details http://aurasystems.com/role/ShareholdersEquityTables 38 false false R39.htm 039 - Disclosure - Shareholders' Equity (Details 2) Sheet http://aurasystems.com/role/ShareholdersEquityDetails2 Shareholders' Equity (Details 2) Details http://aurasystems.com/role/ShareholdersEquityTables 39 false false R40.htm 040 - Disclosure - Shareholders' Equity (Details 3) Sheet http://aurasystems.com/role/ShareholdersEquityDetails3 Shareholders' Equity (Details 3) Details http://aurasystems.com/role/ShareholdersEquityTables 40 false false R41.htm 041 - Disclosure - Shareholders' Equity (Details Textual) Sheet http://aurasystems.com/role/ShareholdersEquityDetailsTextual Shareholders' Equity (Details Textual) Details http://aurasystems.com/role/ShareholdersEquityTables 41 false false R42.htm 042 - Disclosure - Income Taxes (Details) Sheet http://aurasystems.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://aurasystems.com/role/IncomeTaxes 42 false false R43.htm 043 - Disclosure - Segment Information (Details) Sheet http://aurasystems.com/role/SegmentInformationDetails Segment Information (Details) Details http://aurasystems.com/role/SegmentInformationTables 43 false false R44.htm 044 - Disclosure - Segment Information (Details Textual) Sheet http://aurasystems.com/role/SegmentInformationDetailsTextual Segment Information (Details Textual) Details http://aurasystems.com/role/SegmentInformationTables 44 false false R45.htm 045 - Disclosure - Significant Customers (Details) Sheet http://aurasystems.com/role/SignificantCustomersDetails Significant Customers (Details) Details http://aurasystems.com/role/SignificantCustomers 45 false false R46.htm 046 - Disclosure - Related Parties Transactions (Details) Sheet http://aurasystems.com/role/RelatedPartiesTransactionsDetails Related Parties Transactions (Details) Details http://aurasystems.com/role/RelatedPartiesTransactions 46 false false R47.htm 047 - Disclosure - Commitments (Details) Sheet http://aurasystems.com/role/CommitmentsDetails Commitments (Details) Details http://aurasystems.com/role/Commitments 47 false false R48.htm 048 - Disclosure - Subsequent Events (Details) Sheet http://aurasystems.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://aurasystems.com/role/SubsequentEvents 48 false false All Reports Book All Reports ausi-20160531.xml ausi-20160531.xsd ausi-20160531_cal.xml ausi-20160531_def.xml ausi-20160531_lab.xml ausi-20160531_pre.xml true true ZIP 65 0001213900-17-009781-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-17-009781-xbrl.zip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end